An Introduction to Transporters
===============================

The majority of biological solutes are charged organic or inorganic molecules. Cellular membranes are hydrophobic and, therefore, effective barriers to separate them allowing the formation of gradients, which can be exploited, for example, in the generation of energy. Membrane transporters carry solutes across cell membranes, which would otherwise be impermeable to them. The energy required for active transport processes is obtained from ATP turnover or by exploiting ion gradients.

ATP-driven transporters can be divided into three major classes: P-type ATPases; F-type or V-type ATPases and ATP-binding cassette transporters. The first of these, P-type ATPases, are multimeric proteins, which transport (primarily) inorganic cations. The second, F-type or V-type ATPases, are proton-coupled motors, which can function either as transporters or as motors. Last, are ATP-binding cassette transporters, heavily involved in drug disposition as well as transporting endogenous solutes.

The second largest family of membrane proteins in the human genome, after the G protein-coupled receptors, are the SLC solute carrier family. Within the solute carrier family, there are not only a great variety of solutes transported, from simple inorganic ions to amino acids and sugars to relatively complex organic molecules like haem. The solute carrier family includes 52 families of almost 400 members. Many of these overlap in terms of the solutes that they carry. For example, amino acid accumulation is mediated by members of the SLC1, SLC3/7, SLC6, SLC15, SLC16, SLC17, SLC32, SLC36, SLC38 and SLC43. Further members of the SLC superfamily regulate ion fluxes at the plasma membrane, or solute transport into and out of cellular organelles. Some SLC family members remain orphan transporters, in as much as a physiological function has yet to be determined. Within the SLC superfamily, there is an abundance in diversity of structure. Two families (SLC3 and SLC7) only generate functional transporters as heteromeric partners, where one partner is a single TM domain protein. Membrane topology predictions for other families suggest 3, 4, 6, 7, 8, 9, 10, 11, 12, 13, or 14 TM domains. The SLC transporters include members which function as antiports, where solute movement in one direction is balanced by a solute moving in the reverse direction. Symports allow concentration gradients of one solute to allow movement of a second solute across a membrane. A third, relatively small group are equilibrative transporters, which allow solutes to travel across membranes down their concentration gradients. A more complex family of transporters, the SLC27 fatty acid transporters also express enzymatic function. Many of the transporters also express electrogenic properties of ion channels.
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ATP-binding cassette transporter family
=======================================

Overview
--------

ATP-binding cassette transporters are ubiquitous membrane proteins characterized by active ATP-dependent movement of a range of substrates, including ions, lipids, peptides, steroids. Individual subunits are typically made up of two groups of 6TM-spanning domains, with two nucleotide-binding domains (NBD). The majority of eukaryotic ABC transporters are 'full' transporters incorporating both TM and NBD entities. Some ABCs, notably the ABCD and ABCG families are half-transporters with only a single membrane spanning domain and one NBD, and are only functional as homo- or heterodimers. Eukaryotic ABC transporters convey substrates from the cytoplasm, either out of the cell or into intracellular organelles. Their role in the efflux of exogenous compounds, notably chemotherapeutic agents, has led to considerable interest.

ABCA subfamily
==============

  ------------------------- --------------------- ---------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature   Common abbreviation   HGNC, UniProt    Comment
  ABCA1                     ABC1, CERP            ABCA1, O95477    Loss-of-function mutations are associated with Tangier disease, in which plasma HDL cholesterol levels are greatly reduced
  ABCA2                     ABC2                  ABCA2, Q9BZC7    --
  ABCA3                     ABC3, ABCC            ABCA3, Q99758    Loss-of-function mutations are associated with pulmonary surfactant deficiency
  ABCA4                     ABCR                  ABCA4, P78363    Retinal-specific transporter of N-retinylPE; loss-of-function mutations are associated with Stargardt disease, a juvenile onset macular degenerative disease
  ABCA5                     --                    ABCA5, Q8WWZ7    --
  ABCA6                     --                    ABCA6, Q8N139    --
  ABCA7                     --                    ABCA7, Q8IZY2    Genome wide association studies identify ABCA7 variants as associated with Alzheimer\'s Disease [@b6]
  ABCA8                     --                    ABCA8, O94911    --
  ABCA9                     --                    ABCA9, Q8IUA7    --
  ABCA10                    --                    ABCA10, Q8WWZ4   --
  ABCA12                    --                    ABCA12, Q86UK0   Reported to play a role in skin ceramide formation [@b23]
  ABCA13                    --                    ABCA13, Q86UQ4   --
  ------------------------- --------------------- ---------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------

Comments
--------

A number of structural analogues are not found in man: ABCA14 (ENSMUSG00000062017); ABCA15 (ENSMUSG00000054746); ABCA16 (ENSMUSG00000051900) and ABCA17 (ENSMUSG00000035435).

ABCB subfamily
--------------

  ------------------------- --------------------- ---------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature   Common abbreviation   HGNC, UniProt    Comment
  ABCB1                     MDR1, PGP1            ABCB1, P08183    Responsible for the cellular export of many therapeutic drugs. The mouse and rat have two Mdr1 genes (gene names; Mdr1a and Mdr1b) while the human has only the one gene, MDR1
  ABCB2                     TAP1                  TAP1, Q03518     Endoplasmic reticulum peptide transporter, possibly requires heterodimerization with TAP2
  ABCB3                     TAP2                  TAP2, Q03519     Endoplasmic reticulum peptide transporter, possibly requires heterodimerization with TAP1
  ABCB4                     PGY3                  ABCB4, P21439    Transports phosphatidylcholine from intracellular to extracellular face of the hepatocyte canalicular membrane [@b13]
  ABCB5                     --                    ABCB5, Q2M3G0    Multidrug resistance protein in, and marker of, melanoma cells [@b17]
  ABCB6                     MTABC3                ABCB6, Q9NP58    Putative mitochondrial porphyrin transporter [@b11]; other subcellular localizations are possible, such as the plasma membrane, as a specific determinant of the Langereis blood group system [@b5]
  ABCB7                     ABC7                  ABCB7, O75027    Mitochondrial; reportedly essential for haematopoiesis [@b15]
  ABCB8                     MABC1                 ABCB8, Q9NUT2    Mitochondrial; suggested to play a role in chemoresistance of melanoma [@b4]
  ABCB9                     TAPL                  ABCB9, Q9NP78    Reported to be lysosomal [@b7]
  ABCB10                    MTABC2                ABCB10, Q9NRK6   Mitochondrial location; the first human ABC transporter to have a crystal structure reported [@b18]
  ABCB11                    ABC16                 ABCB11, O95342   Loss-of-function mutations are associated with progressive familial intrahepatic cholestasis type 2 [@b19]
  ------------------------- --------------------- ---------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ABCC subfamily
==============

  ------------------------- --------------------- ---------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature   Common abbreviation   HGNC, UniProt    Comment
  ABCC1                     MRP1                  ABCC1, P33527    Exhibits a broad substrate specificity [@b1], including LTC4 (K~m~ 97 nM [@b12]) and estradiol-17β-glucuronide [@b20]
  ABCC2                     MRP2, cMOAT           ABCC2, Q92887    Loss-of-function mutations are associated with Dubin-Johnson syndrome, in which plasma levels of conjugated bilirubin are elevated (OMIM: 237500)
  ABCC3                     MRP3                  ABCC3, O15438    Transports conjugates of glutathione, sulfate or glucuronide [@b2]
  ABCC4                     MRP4                  ABCC4, O15439    Although reported to facilitate cellular cyclic nucleotide export, this role has been questioned [@b2]; reported to export prostaglandins in a manner sensitive to NSAIDS [@b16]
  ABCC5                     MRP5                  ABCC5, O15440    Although reported to facilitate cellular cyclic nucleotide export, this role has been questioned [@b2]
  ABCC6                     MRP6                  ABCC6, O95255    Loss-of-function mutations in ABCC6 are associated with pseudoxanthoma elasticum (OMIM: 264800)
  ABCC10                    MRP7                  ABCC10, Q5T3U5   --
  ABCC11                    MRP8                  ABCC11, Q96J66   Single nucleotide polymorphisms distinguish wet vs. dry earwax (OMIM: 117800); an association between earwax allele and breast cancer risk is reported in Japanese but not European populations
  ABCC12                    MRP9                  ABCC12, Q96J65   --
  ------------------------- --------------------- ---------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comments
========

ABCC7 (also known as CFTR), a 12TM ABC transporter-type protein, is a cAMP-regulated epithelial cell membrane Cl^-^ channel involved in normal fluid transport across various epithelia and can be viewed in the Chloride channels section of the Guide ABCC8 (ENSG00000006071, also known as SUR1, sulfonylurea receptor 1) and ABCC9 (ENSG00000069431, also known as SUR2, sulfonylurea receptor 2) are unusual in that they lack transport capacity but regulate the activity of particular K^+^ channels (Kir6.1--6.2), conferring nucleotide sensitivity to these channels to generate the canonical K~ATP~ channels. ABCC13 (ENSG00000155288) is a possible pseudogene.

ABCD subfamily of peroxisomal ABC transporters
==============================================

Overview
--------

This family of 'half-transporters\' act as homo- or heterodimers to accumulate fatty acid-CoA esters into peroxisomes for oxidative metabolism [@b9].

  ------------------------- --------------------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature   Common abbreviation   HGNC, UniProt   Comment
  ABCD1                     ALDP                  ABCD1, P33897   Transports coenzyme A esters of very long chain fatty acids [@b21],[@b22]; loss-of-function mutations in ABCD1 are associated with adrenoleukodystrophy (OMIM: 3001002)
  ABCD2                     ALDR                  ABCD2, Q9UBJ2   Coenzyme A esters of very long chain unsaturated fatty acids [@b22]
  ABCD3                     PMP70                 ABCD3, P28288   --
  ------------------------- --------------------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comments
========

ABCD4 (ENSG00000119688, also known as PMP69, PXMP1-L or P70R) appears to be located on the endoplasmic reticulum [@b8], with an unclear function. Loss-of-function mutations in the gene encoding ALDP underlie the metabolic storage disorder X-linked adrenoleukodystrophy.

ABCG subfamily
==============

Overview
--------

This family of 'half-transporters\' act as homo- or heterodimers; particularly ABCG5 and ABCG8 are thought to be obligate heterodimers. They are associated with cellular export of sterols and phospholipids, as well as exogenous drugs (ABCG2).

  ------------------------- --------------------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature   Common abbreviation   HGNC, UniProt   Comment
  ABCG1                     ABC8                  ABCG1, P45844   Transports sterols and choline phospholipids [@b10]
  ABCG2                     ABCP                  ABCG2, Q9UNQ0   Exhibits a broad substrate specificity, including urate and haem, as well as multiple synthetic compounds [@b10]. The functional transporter is likely to be a homodimer, although higher oligomeric states have also been proposed
  ABCG4                     --                    ABCG4, Q9H172   Putative functional dependence on ABCG1
  ABCG5                     --                    ABCG5, Q9H222   Transports phytosterols and cholesterol; forms an obligate heterodimer with ABCG8. Loss-of-function mutations in ABCG5 are associated with sitosterolemia (OMIM: 210250)
  ABCG8                     --                    ABCG8, Q9H221   Transports phytosterols and cholesterol; forms an obligate heterodimer with ABCG5. Loss-of-function mutations in ABCG8 are associated with sitosterolemia (OMIM: 210250)
  ------------------------- --------------------- --------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comments
========

A further group of ABC transporter-like proteins have been identified to lack membrane spanning regions and are not believed to be functional transporters, but appear to have a role in protein translation [@b3],[@b14]: ABCE1 (P61221, also known as OABP or 2\'-5\' oligoadenylate-binding protein); ABCF1 (Q8NE71, also known as ABC50 or TNF-α-stimulated ABC protein); ABCF2 (Q9UG63, also known as iron-inhibited ABC transporter 2) and ABCF3 (Q9NUQ8).

F-type and V-type ATPases
=========================

Overview
--------

The F-type (ATP synthase) and the V-type (vacuolar or vesicular proton pump) ATPases, although having distinct subcellular locations and roles, exhibit marked similarities in subunit structure and mechanism. They are both composed of a 'soluble' complex (termed F~1~ or V~1~) and a membrane complex (F~o~ or V~o~). Within each ATPase complex, the two individual sectors appear to function as connected opposing rotary motors, coupling catalysis of ATP synthesis or hydrolysis to proton transport. Both the F-type and V-type ATPases have been assigned enzyme commission number E.C. 3.6.3.14

F-type ATPase
=============

Overview
--------

The F-type ATPase, also known as ATP synthase or ATP phosphohydrolase (H^+^-transporting), is a mitochondrial membrane-associated multimeric complex consisting of two domains, an F~0~ channel domain in the membrane and an F~1~ domain extending into the lumen. Proton transport across the inner mitochondrial membrane is used to drive the synthesis of ATP, although it is also possible for the enzyme to function as an ATPase. The ATP5O subunit (oligomycin sensitivity-conferring protein, OSCP, (P48047)), acts as a connector between F~1~ and F~0~ motors.

The **F~1~ motor**, responsible for ATP turnover, has the subunit composition α3β3γδε.

The **F~0~ motor**, responsible for ion translocation, is complex in mammals, with probably nine subunits centring on A, B, and C subunits in the membrane, together with D, E, F2, F6, G2 and 8 subunits. Multiple pseudogenes for the F~0~ motor proteins have been defined in the human genome.

  --------------- ---------------- --------------- ---------------- --------------- ---------------
  Nomenclature    α subunit        β subunit       γ subunit        δ subunit       ε subunit
  HGNC, UniProt   ATP5A1, P25705   ATP5B, P06576   ATP5C1, P36542   ATP5D, P30049   ATP5E, P56381
  --------------- ---------------- --------------- ---------------- --------------- ---------------

  --------------- ----------------- ---------------- ------------------------------------------------ --------------- --------------- ---------------- --------------- ---------------- -----------------
  Nomenclature    A subunit         B subunit        C subunit                                        D subunit       E subunit       F2 subunit       F6 subunit      G2 subunit       8 subunit
  HGNC, UniProt   MT-ATP6, P00846   ATP5F1, P24539   ATP5G1, P05496; ATP5G2, P48201; ATP5G3, Q06055   ATP5H, O75947   ATP5I, P56385   ATP5J2, P56134   ATP5J, P18859   ATP5L2, Q7Z4Y8   MT-ATP8, P03928
  --------------- ----------------- ---------------- ------------------------------------------------ --------------- --------------- ---------------- --------------- ---------------- -----------------

V-type ATPase
=============

Overview
--------

The V-type ATPase is most prominently associated with lysosomes in mammals, but also appears to be expressed on the plasma membrane and neuronal synaptic vesicles.

The **V~1~ motor**, responsible for ATP turnover, has eight subunits with a composition of A-H.

The**V~o~ motor**, responsible for ion translocation, has six subunits (a-e).

  --------------- ----------------- ------------------ ------------------ ------------------ ------------------ ----------------- ------------------ ------------------ ----------------- ------------------ ------------------ ------------------ -----------------
  Nomenclature    A subunit         B1 subunit         B2 subunit         C1 subunit         C2 subunit         D subunit         E1 subunit         E2 subunit         F subunit         G1 subunit         G2 subunit         G3 subunit         H subunit
  HGNC, UniProt   ATP6V1A, P38606   ATP6V1B1, P15313   ATP6V1B2, P21281   ATP6V1C1, P21283   ATP6V1C2, Q8NEY4   ATP6V1D, Q9Y5K8   ATP6V1E1, P36543   ATP6V1E2, Q96A05   ATP6V1F, Q16864   ATP6V1G1, O75348   ATP6V1G2, O95670   ATP6V1G3, Q96LB4   ATP6V1H, Q9UI12
  --------------- ----------------- ------------------ ------------------ ------------------ ------------------ ----------------- ------------------ ------------------ ----------------- ------------------ ------------------ ------------------ -----------------

  --------------- ------------------ ------------------ ---------------- ------------------ ----------------- ----------------- ------------------ ------------------ ------------------ ------------------
  Nomenclature    a1 subunit         a2 subunit         a3 subunit       a4 subunit         b subunit         c subunit         d1 subunit         d2 subunit         e1 subunit         e2 subunit
  HGNC, UniProt   ATP6V0A1, Q93050   ATP6V0A2, Q9Y487   TCIRG1, Q13488   ATP6V0A4, Q9HBG4   ATP6V0B, Q99437   ATP6V0C, P27449   ATP6V0D1, P61421   ATP6V0D2, Q8N8Y2   ATP6V0E1, O15342   ATP6V0E2, Q8NHE4
  --------------- ------------------ ------------------ ---------------- ------------------ ----------------- ----------------- ------------------ ------------------ ------------------ ------------------

P-type ATPases
==============

Overview
--------

Phosphorylation-type ATPases (EC 3.6.3.-) are associated with membranes and the transport of ions or phospholipids. Characteristics of the family are the transient phosphorylation of the transporters at an aspartate residue and the interconversion between E1 and E2 conformations in the activity cycle of the transporters, taken to represent 'half-channels\' facing the cytoplasm and extracellular/luminal side of the membrane, respectively.

Sequence analysis across multiple species allows the definition of five subfamilies, P1-P5. The P1 subfamily includes heavy metal pumps, such as the copper ATPases. The P2 subfamily includes calcium, sodium/potassium and proton/potassium pumps. The P4 and P5 subfamilies include putative phospholipid flippases.

Na+/K+-ATPases (EC 3.6.3.9)
===========================

Overview
--------

The cell-surface Na^+^/K^+^-ATPase is an integral membrane protein which regulates the membrane potential of the cell by maintaining gradients of Na^+^ and K^+^ ions across the plasma membrane, also making a small, direct contribution to membrane potential, particularly in cardiac cells. For every molecule of ATP hydrolysed, the Na^+^/K^+^-ATPase extrudes three Na^+^ ions and imports two K^+^ ions. The active transporter is a heteromultimer with incompletely defined stoichiometry, possibly as tetramers of heterodimers, each consisting of one of four large, ten TM domain catalytic α subunits and one of three smaller, single TM domain glycoprotein β-subunits (see table). Additional protein partners known as FXYD proteins (*e.g.* FXYD2, P54710) appear to associate with and regulate the activity of the pump.

  --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  Nomenclature    α1 subunit       α2 subunit       α3 subunit       α4 subunit       β1 subunit       β2 subunit       β3 subunit
  HGNC, UniProt   ATP1A1, P05023   ATP1A2, P50993   ATP1A3, P13637   ATP1A4, Q13733   ATP1B1, P05026   ATP1B2, P14415   ATP1B3, P54709
  --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------

Comments
--------

Na^+^/K^+^-ATPases are inhibited by ouabain and cardiac glycosides, such as digoxin, as well as potentially endogenous cardiotonic steroids [@b24].

Ca2+-ATPases (EC 3.6.3.8)
=========================

Overview
--------

The sarcoplasmic/endoplasmic reticulum Ca^2+^-ATPase (SERCA) is an intracellular membrane-associated pump for sequestering calcium from the cytosol into intracellular organelles, usually associated with the recovery phase following excitation of muscle and nerves.

The plasma membrane Ca^2+^-ATPase (PMCA) is a cell-surface pump for extruding calcium from the cytosol, usually associated with the recovery phase following excitation of cells. The active pump is a homodimer, each subunit of which is made up of ten TM segments, with cytosolic C- and N-termini and two large intracellular loops.

Secretory pathway Ca^2+^-ATPases (SPCA) allow accumulation of calcium and manganese in the Golgi apparatus.

  --------------- ---------------- ---------------- ----------------
  Nomenclature    SERCA1           SERCA2           SERCA3
  HGNC, UniProt   ATP2A1, O14983   ATP2A2, P16615   ATP2A3, Q93084
  --------------- ---------------- ---------------- ----------------

Comments
========

The fungal toxin ochratoxin A has been described to activate SERCA in kidney microsomes [@b25]. cyclopiazonic acid [@b29], thapsigargin [@b27] and BHQ are widely employed to block SERCA. Thapsigargin has also been described to block the TRPV1 vanilloid receptor [@b30].

  --------------- ---------------- ---------------- ---------------- ----------------
  Nomenclature    PMCA1            PMCA2            PMCA3            PMCA4
  HGNC, UniProt   ATP2B1, P20020   ATP2B2, Q01814   ATP2B3, Q16720   ATP2B4, P23634
  --------------- ---------------- ---------------- ---------------- ----------------

Comments
========

The stoichiometry of flux through the PMCA differs from SERCA, with the PMCA transporting 1 Ca^2+^ while SERCA transports 2 Ca^2+^.

  --------------- ---------------- ----------------
  Nomenclature    SPCA1            SPCA2
  HGNC, UniProt   ATP2C1, P98194   ATP2C2, O75185
  --------------- ---------------- ----------------

Comments
--------

Loss-of-function mutations in SPCA1 appear to underlie Hailey-Hailey disease [@b26].

H+/K+-ATPases (EC 3.6.3.10)
===========================

Overview
--------

The H^+^/K^+^ ATPase is a heterodimeric protein, made up of α and β subunits. The α subunit has 10 TM domains and exhibits catalytic and pore functions, while the β subunit has a single TM domain, which appears to be required for intracellular trafficking and stabilising the α subunit. The ATP4A and ATP4B subunits are expressed together, while the ATP12A subunit is suggested to be expressed with the β1 (ATP1B1) subunit of the Na^+^/K^+^-ATPase [@b28].

  --------------- --------------- ---------------- ---------------
  Nomenclature    ATP4A           ATP12A           ATP4B
  HGNC, UniProt   ATP4A, P20648   ATP12A, P54707   ATP4B, P51164
  --------------- --------------- ---------------- ---------------

Comments
--------

The gastric H^+^/K^+^-ATPase is inhibited by proton pump inhibitors used for treating excessive gastric acid secretion, including (R)-lansoprazole and a metabolite of esomeprazole.

Cu+-ATPases (EC 3.6.3.4)
========================

Overview
--------

Copper-transporting ATPases convey copper ions across cell-surface and intracellular membranes. They consist of eight TM domains and associate with multiple copper chaperone proteins (*e.g.* ATOX1, O00244).

  --------------- --------------- ---------------
  Nomenclature    ATP7A           ATP7B
  HGNC, UniProt   ATP7A, Q04656   ATP7B, P35670
  --------------- --------------- ---------------

Phospholipid-transporting ATPases (EC 3.6.3.1)
==============================================

Overview
--------

These transporters are thought to translocate the aminophospholipids phosphatidylserine and phosphatidylethanolamine from one side of the phospholipid bilayer to the other to generate asymmetric membranes. They are also proposed to be involved in the generation of vesicles from intracellular and cell-surface membranes.

  --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- --------------- --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------
  Nomenclature    ATP8A1           ATP8A2           ATP8B1           ATP8B2           ATP8B3           ATP8B4           ATP9A           ATP9B           ATP10A           ATP10B           ATP10D           ATP11A           ATP11B           ATP11C
  HGNC, UniProt   ATP8A1, Q9Y2Q0   ATP8A2, Q9NTI2   ATP8B1, O43520   ATP8B2, P98198   ATP8B3, O60423   ATP8B4, Q8TF62   ATP9A, O75110   ATP9B, O43861   ATP10A, O60312   ATP10B, O94823   ATP10D, Q9P241   ATP11A, P98196   ATP11B, Q9Y2G3   ATP11C, Q8NB49
  --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ---------------- --------------- --------------- ---------------- ---------------- ---------------- ---------------- ---------------- ----------------

Comments
--------

Loss-of-function mutations in ATP8B1 are associated with type I familial intrahepatic cholestasis.

A further series of structurally-related proteins have been identified in the human genome, with as yet undefined function, including ATP13A1 (Q9HD20), ATP13A2 (Q9NQ11), ATP13A3 (Q9H7F0), ATP13A4 (Q4VNC1) and ATP13A5 (Q4VNC0).

SLC1 family of amino acid transporters
======================================

Overview
--------

The SLC1 family of sodium dependent transporters includes the plasma membrane located glutamate transporters and the neutral amino acid transporters ASCT1 and ASCT2 [@b31],[@b37],[@b64],[@b65],[@b76].

Glutamate transporter subfamily
===============================

Overview
--------

Glutamate transporters present the unusual structural motif of 8TM segments and 2 re-entrant loops [@b60]. The crystal structure of a glutamate transporter homologue (GltPh) from *Pyrococcus horikoshii* supports this topology and indicates that the transporter assembles as a trimer, where each monomer is a functional unit capable of substrate permeation [@b38],[@b78],[@b93] reviewed by [@b63]). This structural data is in agreement with the proposed quaternary structure for EAAT2 [@b55] and several functional studies that propose the monomer is the functional unit [@b57],[@b67],[@b69],[@b83]. Recent evidence suggests that EAAT3 and EAAT4 may assemble as heterotrimers [@b74]. The activity of glutamate transporters located upon both neurones (predominantly EAAT3, 4 and 5) and glia (predominantly EAAT 1 and 2) serves, dependent upon their location, to regulate excitatory neurotransmission, maintain low ambient extracellular concentrations of glutamate (protecting against excitotoxicity) and provide glutamate for metabolism including the glutamate-glutamine cycle. The Na+/K+-ATPase that maintains the ion gradients that drive transport has been demonstrated to co-assemble with EAAT1 and EAAT2 [@b80]. Recent evidence supports altered glutamate transport and novel roles in brain for splice variants of EAAT1 and EAAT2 [@b54],[@b70]. Three patients with dicarboxylic aminoaciduria (DA) were recently found to have loss-of-function mutations in EAAT3 [@b36]. DA is characterized by excessive excretion of the acidic amino acids glutamate and aspartate and EAAT3 is the predominant glutamate/aspartate transporter in the kidney. Enhanced expression of EAAT2 resulting from administration of β-lactam antibiotics (*e.g.* ceftriaxone) is neuroprotective and occurs through NF-κB-mediated EAAT2 promoter activation [@b53],[@b71],[@b81] reviewed by [@b66]). PPARγ activation (*e.g*. by rosiglitazone) also leads to enhanced expression of EAAT though promoter activation [@b79]. In addition, several translational activators of EAAT2 have recently been described [@b42] along with treatments that increase the surface expression of EAAT2 (*e.g.* [@b68]; [@b98]), or prevent its down-regulation (*e.g.* [@b56]). A thermodynamically uncoupled Cl^-^ flux, activated by Na^+^ and glutamate [@b59],[@b64],[@b73] (Na^+^ and aspartate in the case of GltPh [@b82]), is sufficiently large, in the instances of EAAT4 and EAAT5, to influence neuronal excitability [@b88],[@b92]. Indeed, it has recently been suggested that the primary function of EAAT5 is as a slow anion channel gated by glutamate, rather than a glutamate transporter [@b52].

  ------------------------- --------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------
  Nomenclature              Excitatory amino acid transporter 1                                                                             Excitatory amino acid transporter 2                                                                                                                        Excitatory amino acid transporter 3                                                  Excitatory amino acid transporter 4                                                  Excitatory amino acid transporter 5
  Systematic nomenclature   SLC1A3                                                                                                          SLC1A2                                                                                                                                                     SLC1A1                                                                               SLC1A6                                                                               SLC1A7
  Common abbreviation       EAAT1                                                                                                           EAAT2                                                                                                                                                      EAAT3                                                                                EAAT4                                                                                EAAT5
  HGNC, UniProt             SLC1A3, P43003                                                                                                  SLC1A2, P43004                                                                                                                                             SLC1A1, P43005                                                                       SLC1A6, P48664                                                                       SLC1A7, O00341
  Endogenous substrates     L-glutamic acid, L-aspartic acid                                                                                L-glutamic acid, L-aspartic acid                                                                                                                           L-glutamic acid, L-aspartic acid, L-cysteine [@b94]                                  L-glutamic acid, L-aspartic acid                                                     L-glutamic acid, L-aspartic acid
  Substrates                DL-threo-β-hydroxyaspartate, L-trans-2,4-pyrolidine dicarboxylate, D-aspartic acid                              DL-threo-β-hydroxyaspartate, L-trans-2,4-pyrolidine dicarboxylate, D-aspartic acid                                                                         DL-threo-β-hydroxyaspartate, L-trans-2,4-pyrolidine dicarboxylate, D-aspartic acid   DL-threo-β-hydroxyaspartate, L-trans-2,4-pyrolidine dicarboxylate, D-aspartic acid   DL-threo-β-hydroxyaspartate, L-trans-2,4-pyrolidine dicarboxylate, D-aspartic acid
  Inhibitors (pIC~50~)      DL-TBOA (p*K*~B~ 5.0) [@b85], UCPH-101 (membrane potential assay) (6.9) [@b62]                                  DL-TBOA (p*K*~B~ 6.9) [@b85], SYM2081 (p*K*~B~ 5.5) [@b91], dihydrokainate (p*K*~B~ 5.0), threo-3-methylglutamate (p*K*~B~ 4.7) [@b91], WAY-213613 (6.9)   NBI-59159 (7.6), L-β-BA (\[^3^H\]D-aspartate uptake assay) (6.1), DL-TBOA (5.1)      DL-TBOA (p*K*~i~ 5.4) [@b84], threo-3-methylglutamate (p*K*~i~ 4.3) [@b47]           DL-TBOA (p*K*~i~ 5.5) [@b84]
  Radioligands (*K*~d~)     \[3H\](2S,4R)-4-methylglutamate, \[3H\]D-aspartic acid, \[3H\]L-aspartic acid, \[3H\]ETB-TBOA (1.55x10^−8^ M)   \[3H\](2S,4R)-4-methylglutamate, \[3H\]D-aspartic acid, \[3H\]L-aspartic acid, \[3H\]ETB-TBOA (1.62x10^−8^ M)                                              \[3H\]D-aspartic acid, \[3H\]L-aspartic acid, \[3H\]ETB-TBOA (3.2x10^−7^ M)          \[3H\]D-aspartic acid, \[3H\]L-aspartic acid, \[3H\]ETB-TBOA (2.48x10^−8^ M)         \[3H\]D-aspartic acid, \[3H\]L-aspartic acid, \[3H\]ETB-TBOA (2.95x10^−8^ M)
  Stoichiometry             Probably 3 Na^+^: 1 H^+^: 1 glutamate (in): 1 K^+^ (out)                                                        3 Na^+^: 1 H^+^: 1 glutamate (in): 1 K^+^ (out) [@b72]                                                                                                     3 Na^+^: 1 H^+^: 1 glutamate (in): 1 K^+^ (out) [@b95]                               Probably 3 Na^+^: 1 H^+^: 1 glutamate (in): 1 K^+^(out)                              Probably 3 Na^+^: 1 H^+^: 1 glutamate (in): 1 K^+^ (out)
  ------------------------- --------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------

Comments
--------

The K~B~ (or K~i~) values reported, unless indicated otherwise, are derived from transporter currents mediated by EAATs expressed in voltage-clamped *Xenopus laevis* oocytes [@b47],[@b84],[@b85],[@b91]. K~B~ (or K~i~) values derived in uptake assays are generally higher (*e.g.* [@b85]). In addition to acting as a poorly transportable inhibitor of EAAT2, (2S,4R)-4-methylglutamate, also known as SYM2081, is a competitive substrate for EAAT1 (K~M~ = 54μM; [@b61],[@b91]) and additionally is a potent kainate receptor agonist [@b97] which renders the compound unsuitable for autoradiographic localisation of EAATs [@b33]. Similarly, at concentrations that inhibit EAAT2, dihydrokainate binds to kainate receptors [@b85]. WAY-855 and WAY-213613 are both non-substrate inhibitors with a preference for EAAT2 over EAAT3 and EAAT1 [@b45],[@b46]. NBI-59159 is a non-substrate inhibitor with modest selectivity for EAAT3 over EAAT1 (\>10-fold) and EAAT2 (5-fold) [@b43],[@b44]. Analogously, L-β-*threo*-benzyl-aspartate (L-β-BA) is a competitive non-substrate inhibitor that preferentially blocks EAAT3 versus EAAT1, or EAAT2 [@b48]. \[3H\](2S,4R)-4-methylglutamate demonstrates low affinity binding (K~D~ ≅ 6.0 μM) to EAAT1 and EAAT2 in rat brain homogenates [@b34] and EAAT1 in murine astrocyte membranes [@b32], whereas \[3H\]ETB-TBOA binds with high affinity to all EAATs other than EAAT3 [@b86]. The novel isoxazole derivative (--)-HIP-A may interact at the same site as TBOA and preferentially inhibit reverse transport of glutamate [@b41]. threo-3-methylglutamate induces substrate-like currents at EAAT4, but does not elicit heteroexchange of \[^3^H\]-aspartate in synaptosome preparations, inconsistent with the behaviour of a substrate inhibitor [@b47]. parawixin 1, a compound isolated from the venom from the spider *Parawixia bistriata* is a selective enhancer of the glutamate uptake through EAAT2 but not through EAAT1 or EAAT3 [@b50],[@b51]. In addition to the agents listed in the table, DL-threo-β-hydroxyaspartate and L-trans-2,4-pyrolidine dicarboxylate act as non-selective competitive substrate inhibitors of all EAATs. Zn^2+^ and arachidonic acid are putative endogenous modulators of EAATs with actions that differ across transporter subtypes (reviewed by [@b90]).

Alanine/serine/cysteine transporter subfamily
=============================================

Overview
--------

ASC transporters mediate Na^+^-dependent exchange of small neutral amino acids such as Ala, Ser, Cys and Thr and their structure is predicted to be similar to that of the glutamate transporters [@b35],[@b89]. ASCT1 and ASCT2 also exhibit thermodynamically uncoupled chloride channel activity associated with substrate transport [@b40],[@b96]. Whereas EAATs counter-transport K^+^ (see above) ASCTs do not and their function is independent of the intracellular concentration of K^+^ [@b96].

  ------------------------- ---------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Nomenclature              Alanine/serine/cysteine transporter 1                                                          Alanine/serine/cysteine transporter 2
  Systematic nomenclature   SLC1A4                                                                                         SLC1A5
  Common abbreviation       ASCT1                                                                                          ASCT2
  HGNC, UniProt             SLC1A4, P43007                                                                                 SLC1A5, Q15758
  Endogenous substrates     L-cysteine \> L-alanine = L-serine \> L-threonine                                              L-alanine = L-serine = L-cysteine (low Vmax) = L-threonine = L-glutamine = L-asparagine \>\> L-methionine ≅ glycine ≅ L-leucine \> L-valine \> L-glutamic acid (enhanced at low pH)
  Inhibitors (pIC~50~)      --                                                                                             benzylcysteine [@b58], benzylserine [@b58], p-nitrophenyl glutamyl anilide [@b49]
  Stoichiometry             1 Na^+^: 1 amino acid (in): 1 Na^+^: 1 amino acid (out); (homo-, or hetero-exchange; [@b95])   1 Na^+^: 1 amino acid (in): 1 Na^+^: 1 amino acid (out); (homo-, or hetero-exchange; [@b39])
  ------------------------- ---------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Comments
--------

The substrate specificity of ASCT1 may extend to L-proline and L-hydroxyproline [@b77]. At low pH (∼5.5) both ASCT1 and ASCT2 are able to exchange acidic amino acids such as L-cysteate and glutamate [@b87],[@b89]. In addition to the inhibitors tabulated above, HgCl~2~, methylmercury, mersalyl, at low micromolar concentrations, non-competitively inhibit ASCT2 by covalent modificiation of cysteine residues [@b75].

SLC2 family of hexose and sugar alcohol transporters
====================================================

Overview
--------

The SLC2 family transports D-glucose, D-fructose, inositol (*e.g.* myo-inositol) and related hexoses. Three classes of glucose transporter can be identified, separating GLUT1-4 and 14, GLUT6, 8, 10 and 12; and GLUT5, 7, 9 and 11. Modelling suggests a 12 TM membrane topology, with intracellular termini, with functional transporters acting as homodimers or homotetramers.

Class I transporters
====================

Overview
--------

Class I transporters are able to transport D-glucose, but not D-fructose, in the direction of the concentration gradient and may be inhibited non-selectively by phloretin and cytochalasin B. GLUT1 is the major glucose transporter in brain, placenta and erythrocytes, GLUT2 is found in the pancreas, liver and kidneys, GLUT3 is neuronal and placental, while GLUT4 is the insulin-responsive transporter found in skeletal muscle, heart and adipose tissue. GLUT14 appears to result from gene duplication of GLUT3 and is expressed in the testes [@b105].

  ------------------------- ---------------------------------------------------------------- ------------------------------------ ----------------------- ----------------------------------- ------------------------
  Nomenclature              Glucose transporter 1                                            Glucose transporter 2                Glucose transporter 3   Glucose transporter 4               Glucose transporter 14
  Systematic nomenclature   SLC2A1                                                           SLC2A2                               SLC2A3                  SLC2A4                              SLC2A14
  Common abbreviation       GLUT1                                                            GLUT2                                GLUT3                   GLUT4                               GLUT14
  HGNC, UniProt             SLC2A1, P11166                                                   SLC2A2, P11168                       SLC2A3, P11169          SLC2A4, P14672                      SLC2A14, Q8TDB8
  Substrates                D-glucose = D-glucosamine [@b104], dehydroascorbic acid [@b99]   D-glucosamine \> D-glucose [@b104]   D-glucose               D-glucosamine ≥ D-glucose [@b104]   --
  Radioligands (*K*~d~)     \[3H\]2-deoxyglucose                                             \[3H\]2-deoxyglucose                 \[3H\]2-deoxyglucose    \[3H\]2-deoxyglucose                --
  ------------------------- ---------------------------------------------------------------- ------------------------------------ ----------------------- ----------------------------------- ------------------------

Class II transporters
=====================

Overview
--------

Class II transporters transport D-fructose and appear to be insensitive to cytochalasin B. Class II transporters appear to be predominantly intracellularly located.

  ------------------------- ----------------------- ----------------------- ------------------------------------------------- ------------------------
  Nomenclature              Glucose transporter 6   Glucose transporter 8   Glucose transporter 10                            Glucose transporter 12
  Systematic nomenclature   SLC2A6                  SLC2A8                  SLC2A10                                           SLC2A12
  Common abbreviation       GLUT6                   GLUT8                   GLUT10                                            GLUT12
  HGNC, UniProt             SLC2A6, Q9UGQ3          SLC2A8, Q9NY64          SLC2A10, O95528                                   SLC2A12, Q8TD20
  Substrates                --                      D-glucose [@b101]       D-glucose [@b102], dehydroascorbic acid [@b102]   D-glucose [@b103]
  ------------------------- ----------------------- ----------------------- ------------------------------------------------- ------------------------

Proton-coupled inositol transporter
===================================

Overview
--------

Proton-coupled inositol transporters are expressed predominantly in the brain and can be inhibited by phloretin and cytochalasin B [@b104].

  ------------------------- ------------------------------------------------------------------------------------------------
  Nomenclature              Proton myo-inositol cotransporter
  Systematic nomenclature   SLC2A13
  Common abbreviation       HMIT
  HGNC, UniProt             SLC2A13, Q96QE2
  Substrates                myo-inositol [@b104], D-chiro-inositol [@b104], muco-inositol [@b104], scyllo-inositol [@b104]
  Stoichiometry             1 H^+^: 1 inositol (in) [@b100]
  ------------------------- ------------------------------------------------------------------------------------------------

SLC3 and SLC7 families of heteromeric amino acid transporters (HATs)
====================================================================

Overview
--------

The SLC3 and SLC7 families combine to generate functional transporters, where the subunit composition is a disulphide-linked combination of a heavy chain (SLC3 family) with a light chain (SLC7 family).

SLC3 family
===========

Overview
--------

SLC3 family members are single TM proteins with extensive glycosylation of the exterior C-terminus, which heterodimerize with SLC7 family members in the endoplasmic reticulum and assist in the plasma membrane localization of the transporter.

  ------------------------- ---------------- ----------------
  Nomenclature              rBAT             4F2hc
  Systematic nomenclature   SLC3A1           SLC3A2
  Common abbreviation       rBAT             4F2hc
  HGNC, UniProt             SLC3A1, Q07837   SLC3A2, P08195
  ------------------------- ---------------- ----------------

SLC7 family
===========

Overview
--------

SLC7 family members may be divided into two major groups: cationic amino acid transporters (CATs) and glycoprotein-associated amino acid transporters (gpaATs).

Cationic amino acid transporters are 14 TM proteins, which mediate pH- and sodium-independent transport of cationic amino acids (system y^+^), apparently as an exchange mechanism. These transporters are sensitive to inhibition by N-ethylmaleimide.

  ------------------------- ------------------------------------------------- ------------------------------------------------ ----------------------------------- ----------------------------------- ------------------------------------------
  Nomenclature              High affinity cationic amino acid transporter 1   Low affinity cationic amino acid transporter 2   Cationic amino acid transporter 3   Cationic amino acid transporter 4   Probable cationic amino acid transporter
  Systematic nomenclature   SLC7A1                                            SLC7A2                                           SLC7A3                              SLC7A4                              SLC7A14
  Common abbreviation       CAT1                                              CAT2                                             CAT3                                CAT4                                --
  HGNC, UniProt             SLC7A1, P30825                                    SLC7A2, P52569                                   SLC7A3, Q8WY07                      SLC7A4, O43246                      SLC7A14, Q8TBB6
  Substrates                L-arginine, L-lysine, L-ornithine, L-histidine    L-arginine, L-lysine, L-ornithine, L-histidine   L-arginine, L-lysine, L-ornithine   --                                  --
  ------------------------- ------------------------------------------------- ------------------------------------------------ ----------------------------------- ----------------------------------- ------------------------------------------

Glycoprotein-associated amino acid transporters are 12 TM proteins, which heterodimerize with members of the SLC3 family to act as cell-surface amino acid exchangers.

  ------------------------- --------------------------------- --------------------------------- ------------------------------ ------------------------------ ------------------------------------ ----------------------------------- -------------------------------
  Nomenclature              L-type amino acid transporter 1   L-type amino acid transporter 2   y+L amino acid transporter 1   y+L amino acid transporter 2   b0,+-type amino acid transporter 1   Asc-type amino acid transporter 1   Cystine/glutamate transporter
  Systematic nomenclature   SLC7A5                            SLC7A8                            SLC7A7                         SLC7A6                         SLC7A9                               SLC7A10                             SLC7A11
  Common abbreviation       LAT1                              LAT2                              y+LAT1                         y+LAT2                         b^0,+^AT                             Asc-1                               xCT
  HGNC, UniProt             SLC7A5, Q01650                    SLC7A8, Q9UHI5                    SLC7A7, Q9UM01                 SLC7A6, Q92536                 SLC7A9, P82251                       SLC7A10, Q9NS82                     SLC7A11, Q9UPY5
  ------------------------- --------------------------------- --------------------------------- ------------------------------ ------------------------------ ------------------------------------ ----------------------------------- -------------------------------

Comments
========

CAT4 appears to be non-functional in heterologous expression [@b106], while SLC7A14 has yet to be characterized.

Heterodimers between 4F2hc and LAT1 or LAT2 generate sodium-independent system L transporters. LAT1 transports large neutral amino acids including branched-chain and aromatic amino acids as well as miglustat, whereas LAT2 transports most of the neutral amino acids.

Heterodimers between 4F2hc and y^+^LAT1 or y^+^LAT2 generate transporters similar to the system y^+^L, which transport cationic (L-arginine, L-lysine, L-ornithine) amino acids independent of sodium and neutral (L-leucine, L-isoleucine, L-methionine, L-glutamine) amino acids in a partially sodium-dependent manner. These transporters are N-ethylmaleimide-insensitive. Heterodimers between rBAT and b^0,+^AT appear to mediate sodium-independent system b^0,+^ transport of most of the neutral amino acids and cationic amino acids (L-arginine, L-lysine and L-ornithine).

Asc-1 appears to heterodimerize with 4F2hc to allow the transport of small neutral amino acids (such as L-alanine, L-serine, L-threonine, L-glutamine and glycine), as well as D-serine, in a sodium-independent manner.

xCT generates a heterodimer with 4F2hc for a system x^-^~e-c~ transporter that mediates the sodium-independent exchange of L-cystine and L-glutamic acid.

AGT has been conjugated with SLC3 members as fusion proteins to generate functional transporters, but the identity of a native heterodimer has yet to be ascertained.

SLC4 family of bicarbonate transporters
=======================================

Overview
--------

Together with the SLC26 family, the SLC4 family of transporters subserve anion exchange, principally of chloride and bicarbonate (HCO3-), but also carbonate and hydrogen sulphate (HSO4-). SLC4 family members regulate bicarbonate fluxes as part of carbon dioxide movement, chyme neutralization and reabsorption in the kidney.

Within the family, subgroups of transporters are identifiable: the electroneutral sodium-independent Cl^-^/HCO~3~^-^ transporters (AE1, AE2 and AE3), the electrogenic sodium-dependent HCO~3~^-^ transporters (NBCe1 and NBCe2) and the electroneutral HCO~3~^-^ transporters (NBCn1 and NBCn2). Topographical information derives mainly from study of AE1, abundant in erythrocytes, which suggests a dimeric or tetrameric arrangement, with subunits made up of 13 TM domains and re-entrant loops at TM9/10 and TM11/12. The N terminus exhibits sites for interaction with multiple proteins, including glycolytic enzymes, haemoglobin and cytoskeletal elements.

Anion exchangers
================

  ------------------------- --------------------------------- --------------------------------- --------------------------------- --------------------------
  Nomenclature              Anion exchange protein 1          Anion exchange protein 2          Anion exchange protein 3          Anion exchange protein 4
  Systematic nomenclature   SLC4A1                            SLC4A2                            SLC4A3                            SLC4A9
  Common abbreviation       AE1                               AE2                               AE3                               AE4
  HGNC, UniProt             SLC4A1, P02730                    SLC4A2, P04920                    SLC4A3, P48751                    SLC4A9, Q96Q91
  Endogenous substrates     Cl-, HCO3-                        Cl-, HCO3-                        Cl-, HCO3-                        --
  Stoichiometry             1 Cl^-^ (in): 1 HCO~3~^-^ (out)   1 Cl^-^ (in): 1 HCO~3~^-^ (out)   1 Cl^-^ (in): 1 HCO~3~^-^ (out)   --
  ------------------------- --------------------------------- --------------------------------- --------------------------------- --------------------------

Sodium-dependent HCO3- transporters
===================================

  ------------------------- ----------------------------------------------------- ----------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ----------------------------------------- -----------------
  Nomenclature              Electrogenic sodium bicarbonate cotransporter 1       Electrogenic sodium bicarbonate cotransporter 4       Electroneutral sodium bicarbonate cotransporter 1   Electroneutral sodium bicarbonate cotransporter 2   NBCBE                                     NaBC1
  Systematic nomenclature   SLC4A4                                                SLC4A5                                                SLC4A7                                              SLC4A10                                             SLC4A8                                    SLC4A11
  Common abbreviation       NBCe1                                                 NBCe2                                                 NBCn1                                               NBCn2                                               NDCBE                                     BTR1
  HGNC, UniProt             SLC4A4, Q9Y6R1                                        SLC4A5, Q9BY07                                        SLC4A7, Q9Y6M7                                      SLC4A10, Q6U841                                     SLC4A8, Q2Y0W8                            SLC4A11, Q8NBS3
  Endogenous substrates     NaHCO3-                                               NaHCO3-                                               NaHCO3-                                             NaHCO3-                                             Cl-, NaHCO3-                              Cl-, NaHCO3-
  Stoichiometry             1 Na^+^: 2/3 HCO~3~^-^ (out) or 1 Na^+^: CO~3~^2\*^   1 Na^+^: 2/3 HCO~3~^-^ (out) or 1 Na^+^: CO~3~^2\*^   1 Na^+^: 1 HCO~3~^-^ (out) or 1 Na^+^: CO~3~^2\*^   1 Na^+^: 1 HCO~3~^-^ (out) or 1 Na: CO~3~^2\*^      1 Na^+^: 2HCO~3~^-^ (in): 1 Cl^-^ (out)   --
  ------------------------- ----------------------------------------------------- ----------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ----------------------------------------- -----------------

SLC5 family of sodium-dependent glucose transporters
====================================================

Overview
--------

The SLC5 family of sodium-dependent glucose transporters includes, in mammals, the Na^+^/substrate co-transporters for glucose (*e.g.* choline), D-glucose, monocarboxylates, myo-inositol and I^-^ [@b121],[@b122],[@b142],[@b143]. Members of the SLC5 and SLC6 families, along with other unrelated Na^+^ cotransporters (*i.e.* Mhp1 and BetP), share a common structural core that contains an inverted repeat of 5TM α-helical domains [@b107].

Hexose transporter family
=========================

Overview
--------

Detailed characterisation of members of the hexose transporter family is limited to SGLT1, 2 and 3, which are all inhibited in a competitive manner by phlorizin, a natural dihydrocholine glucoside, that exhibits modest selectivity towards SGLT2 (see [@b142] for an extensive review). SGLT1 is predominantly expressed in the small intestine, mediating the absorption of glucose (*e.g.* D-glucose), but also occurs in the brain, heart and in the late proximal straight tubule of the kidney. The expression of SGLT2 is almost exclusively restricted to the early proximal convoluted tubule of the kidney, where it is largely responsible for the renal reabsorption of glucose. SGLT3 is not a transporter but instead acts as a glucosensor generating an inwardly directed flux of Na^+^ that causes membrane depolarization [@b117].

  ------------------------- ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------- ----------------------------- ------------------------
  Nomenclature              SGLT1                                                                                                                    SGLT2                                                                                                                    SGLT3                                                                                                                SGLT4                         SGLT5
  Systematic nomenclature   SLC5A1                                                                                                                   SLC5A2                                                                                                                   SLC5A4                                                                                                               SLC5A9                        SLC5A10
  Common abbreviation       SGLT1                                                                                                                    SGLT2                                                                                                                    SGLT3                                                                                                                SGLT4                         SGLT5
  HGNC, UniProt             SLC5A1, P13866                                                                                                           SLC5A2, P31639                                                                                                           SLC5A4, Q9NY91                                                                                                       SLC5A9, Q2M3M2                SLC5A10, A0PJK1
  Substrates                D-glucose, α-MDG, D-galactose                                                                                            D-glucose, α-MDG                                                                                                         D-glucose, N-ethyl-1-deoxynojirimycin, 1-deoxynojirimycin, 1-deoxynojirimycin-1-sulfonic acid, miglustat, miglitol   D-glucose, α-MDG, D-mannose   D-glucose, D-galactose
  Inhibitors (pIC~50~)      remogliflozin (p*K*~i~ 5.4), sergliflozin (p*K*~i~ 5.1), canagliflozin (6.4), dapagliflozin (5.9), empagliflozin (5.1)   remogliflozin (p*K*~i~ 7.9), sergliflozin (p*K*~i~ 6.8), dapagliflozin (9.0), canagliflozin (8.7), empagliflozin (8.5)   --                                                                                                                   --                            --
  Stoichiometry             2 Na^+^: 1 glucose [@b129]                                                                                               1 Na^+^: 1 glucose [@b127]                                                                                               --                                                                                                                   --                            --
  ------------------------- ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------- ----------------------------- ------------------------

Comments
--------

Recognition and transport of substrate by SGLTs requires that the sugar is a pyranose. De-oxyglucose derivatives have reduced affinity for SGLT1, but the replacement of the sugar equatorial hydroxyl group by fluorine at some positions, excepting C2 and C3, is tolerated (see [@b142] for a detailed quantification). Although SGLT1 and SGLT2 have been described as high- and low-affinity sodium glucose co-transporters, respectively, recent work suggests that they have a similar affinity for glucose under physiological conditions [@b127]. Selective blockers of SGLT2, and thus blocking ∼50% of renal glucose reabsorption, are in use and in further development for the treatment of diabetes (*e.g.* [@b113]).

Choline transporter
===================

Overview
--------

The high affinity, hemicholinium-3-sensitive, choline transporter (CHT) is expressed mainly in cholinergic neurones on nerve cell terminals and synaptic vesicles (keratinocytes being an additional location). In autonomic neurones, expression of CHT requires an activity-dependent retrograde signal from postsynaptic neurones [@b130]. Through recapture of choline generated by the hydrolysis of ACh by acetylcholinesterase, CHT serves to maintain acetylcholine synthesis within the presynaptic terminal [@b121]. Homozygous mice engineered to lack CHT die within one hour of birth as a result of hypoxia arising from failure of transmission at the neuromuscular junction of the skeletal muscles that support respiration [@b120]. A low affinity choline uptake mechanism that remains to be identified at the molecular level may involve multiple transporters. In addition, a family of choline transporter-like (CTL) proteins, (which are members of the SLC44 family) with weak Na^+^ dependence have been described [@b140].

  -------------------------------- ----------------------------------------------------------------------------------
  Nomenclature                     CHT
  Systematic nomenclature          SLC5A7
  Common abbreviation              CHT
  HGNC, UniProt                    SLC5A7, Q9GZV3
  Endogenous substrates            choline
  Substrates                       triethylcholine
  Selective inhibitors (pIC~50~)   hemicholinium-3 (p*K*~i~ 8.3 -- 9.0)
  Radioligands (*K*~d~)            \[3H\]hemicholinium-3 (4x10^-9^ -- 6x10^-9^ M)
  Stoichiometry                    Na^+^: choline (variable stoichimetry); modulated by extracellular Cl^-^ [@b128]
  -------------------------------- ----------------------------------------------------------------------------------

Comments
--------

K~i~ and K~D~ values for hemicholinium-3 listed in the table are for human CHT expressed in *Xenopus laevis* oocytes [@b133], or COS-7 cells [@b109]. hemicholinium mustard is a substrate for CHT that causes covalent modification and irreversible inactivation of the transporter. Several exogenous substances (*e.g.* triethylcholine) that are substrates for CHT act as precursors to cholinergic false transmitters.

Sodium iodide symporter, sodium-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters
==================================================================================================================

Overview
--------

The sodium-iodide symporter (NIS) is an iodide transporter found principally in the thyroid gland where it mediates the accumulation of I^-^ within thyrocytes. Transport of I^-^ by NIS from the blood across the basolateral membrane followed by apical efflux into the colloidal lumen, mediated at least in part by pendrin (SLC22A4), and most likely not SMCT1 (SLC5A8) as once thought, provides the I^-^ required for the synthesis of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) [@b111]. NIS is also expressed in the salivary glands, gastric mucosa, intestinal enterocytes and lactating breast. NIS mediates I^-^ absorption in the intestine and I^-^ secretion into the milk. SMVT is expressed on the apical membrane of intestinal enterocytes and colonocytes and is the main system responsible for biotin (vitamin H) and pantothenic acid (vitamin B~5~) uptake in humans [@b135]. SMVT located in kidney proximal tubule epithelial cells mediates the reabsorption of biotin and pantothenic acid. SMCT1 (SLC5A8), which transports a wide range of monocarboxylates, is expressed in the apical membrane of epithelia of the small intestine, colon, kidney, brain neurones and the retinal pigment epithelium [@b122]. SMCT2 (SLC5A12) also localises to the apical membrane of kidney, intestine, and colon, but in the brain and retina is restricted to astrocytes and Müller cells, respectively [@b122]. SMCT1 is a high-affinity transporter whereas SMCT2 is a low-affinity transporter. The physiological substrates for SMCT1 and SMCT2 are lactate (L-lactic acid and D-lactic acid), pyruvic acid, propanoic acid, and nicotinic acid in non-colonic tissues such as the kidney. SMCT1 is also likely to be the principal transporter for the absorption of nicotinic acid (vitamin B~3~) in the intestine and kidney [@b124]. In the small intestine and colon, the physiological substrates for these transporters are nicotinic acid and the short-chain fatty acids acetic acid, propanoic acid, and butyric acid that are produced by bacterial fermentation of dietary fiber [@b132]. In the kidney, SMCT2 is responsible for the bulk absorption of lactate because of its low-affinity/high-capacity nature. Absence of both transporters in the kidney leads to massive excretion of lactate in urine and consequently drastic decrease in the circulating levels of lactate in blood [@b138]. SMCT1 also functions as a tumour suppressor in the colon as well as in various other non-colonic tissues [@b123]. The tumour-suppressive function of SMCT1 is based on its ability to transport pyruvic acid, an inhibitor of histone deacetylases, into cells in non-colonic tissues [@b139]; in the colon, the ability of SMCT1 to transport butyric acid and propanoic acid, also inhibitors of histone deacetylases, underlies the tumour-suppressive function of this transporter [@b122],[@b123],[@b125]. The ability of SMCT1 to promote histone acetylase inhibition through accumulation of butyric acid and propanoic acid in immune cells is also responsible for suppression of dendritic cell development in the colon [@b137].

  ------------------------- ----------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------
  Nomenclature              NIS                                                   SMVT                                                                          SMCT1                                                                                                                                                                                                                                                                                                                                                    SMCT2
  Systematic nomenclature   SLC5A5                                                SLC5A6                                                                        SLC5A8                                                                                                                                                                                                                                                                                                                                                   SLC5A12
  Common abbreviation       NIS                                                   SMVT                                                                          SMCT1                                                                                                                                                                                                                                                                                                                                                    SMCT2
  HGNC, UniProt             SLC5A5, Q92911                                        SLC5A6, Q9Y289                                                                SLC5A8, Q8N695                                                                                                                                                                                                                                                                                                                                           SLC5A12, Q1EHB4
  Substrates                NO3-, pertechnetate, perchlorate, thiocyanate, I^-^   pantothenic acid [@b116], I^-^ [@b116], biotin [@b116], lipoic acid [@b116]   acetic acid, butyric acid, propanoic acid, nicotinic acid, β-D-hydroxybutyric acid, L-lactic acid, D-lactic acid, salicylic acid, 3-bromopyruvate, dichloroacetate, 2-oxothiazolidine-4-carboxylate, acetoacetic acid, benzoate, 5-aminosalicylate, α-ketoisocaproate, β-L-hydroxybutyric acid, pyroglutamic acid, γ-hydroxybutyric acid, pyruvic acid   nicotinic acid, L-lactic acid, pyruvic acid
  Inhibitors (pIC~50~)      --                                                    --                                                                            fenoprofen, ketoprofen, ibuprofen (4.2)                                                                                                                                                                                                                                                                                                                  --
  Stoichiometry             2Na^+^: 1 I^-^ [@b119]; 1Na^+^: 1 ClO~4~^-^ [@b118]   2Na^+^: 1 biotin (or pantothenic acid) [@b134]                                2Na^+^: 1 monocarboxylate [@b114]                                                                                                                                                                                                                                                                                                                        --
  ------------------------- ----------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------

Comments
--------

I^-^, perchlorate, thiocyanate and NO3- are competitive substrate inhibitors of NIS [@b118]. lipoic acid appears to act as a competitive substrate inhibitor of SMVT [@b141] and the anticonvulsant drugs primidone and carbamazepine competitively block the transport of biotin by brush border vesicles prepared from human intestine [@b136].

Sodium *myo*-inositol cotransporter transporters
================================================

Overview
--------

Three different mammalian myo-inositol cotransporters are currently known; two are the Na^+^-coupled SMIT1 and SMIT2 tabulated below and the third is proton-coupled HMIT (SLC2A13). SMIT1 and SMIT2 have a widespread and overlapping tissue location but in polarized cells, such as the Madin-Darby canine kidney cell line, they segregate to the basolateral and apical membranes, respectively [@b110]. In the nephron, SMIT1 mediates myo-inositol uptake as a 'compatible osmolyte' when inner medullary tubules are exposed to increases in extracellular osmolality, whilst SMIT2 mediates the reabsorption of myo-inositol from the filtrate. In some species (*e.g.* rat, but not rabbit) apically located SMIT2 is responsible for the uptake of myo-inositol from the intestinal lumen [@b108].

  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------
  Nomenclature              SMIT                                                                                                                                                     SGLT6
  Systematic nomenclature   SLC5A3                                                                                                                                                   SLC5A11
  Common abbreviation       SMIT1                                                                                                                                                    SMIT2
  HGNC, UniProt             SLC5A3, P53794                                                                                                                                           SLC5A11, Q8WWX8
  Substrates                myo-inositol, scyllo-inositol \> L-fucose \> L-xylose \> L-glucose, D-glucose, α-methyl-D-glucopyranoside \> D-galactose, D-fucose \> D-xylose [@b126]   myo-inositol = D-chiro-inositol\> D-glucose \> D-xylose \> L-xylose [@b115]
  Inhibitors (pIC~50~)      phlorizin                                                                                                                                                phlorizin
  Stoichiometry             2 Na^+^ :1 *myo*-inositol [@b126]                                                                                                                        2 Na^+^ :1 *myo*-inositol [@b112]
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------

Comments
--------

The data tabulated are those for dog SMIT1 and rabbit SMIT2. SMIT2 transports D-chiro-inositol, but SMIT1 does not. In addition, whereas SMIT1 transports both D-xylose and L-xylose and D-fucose and L-fucose, SMIT2 transports only the D-isomers of these sugars [@b115],[@b126]. Thus the substrate specificities of SMIT1 (for L-fucose ) and SMIT2 (for D-chiro-inositol) allow discrimination between the two SMITs. Human SMIT2 appears not to transport glucose [@b131].

SLC6 neurotransmitter transporter family
========================================

Overview
--------

Members of the solute carrier family 6 (SLC6) of sodium- and (sometimes chloride-) dependent neurotransmitter transporters [@b152],[@b156],[@b179] are primarily plasma membrane located and may be divided into four subfamilies that transport monoamines, GABA, glycine and neutral amino acids, plus the related bacterial NSS transporters [@b189]. The members of this superfamily share a structural motif of 10 TM segments that has been observed in crystal structures of the NSS bacterial homolog LeuT~Aa~, a Na^+^-dependent amino acid transporter from *Aquiflex aeolicus* [@b206] and in several other transporter families structurally related to LeuT [@b164].

Monoamine transporter subfamily
===============================

Overview
--------

Monoamine neurotransmission is limited by perisynaptic transporters. Presynaptic monoamine transporters allow recycling of synaptically released noradrenaline, dopamine and 5-hydroxytryptamine (5-HT).

  -------------------------------- --------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------
  Nomenclature                     Noradrenaline transporter                                                                                       Dopamine transporter                                                       5HT transporter
  Systematic nomenclature          SLC6A2                                                                                                          SLC6A3                                                                     SLC6A4
  Common abbreviation              NET                                                                                                             DAT                                                                        SERT
  HGNC, UniProt                    SLC6A2, P23975                                                                                                  SLC6A3, Q01959                                                             SLC6A4, P31645
  Endogenous substrates            (-)-adrenaline, (-)-noradrenaline, dopamine                                                                     (-)-adrenaline, (-)-noradrenaline, dopamine                                5-HT
  Substrates                       MPP+, methamphetamine, amphetamine                                                                              MPP+, methamphetamine, amphetamine                                         MDMA, p-chloroamphetamine
  Selective inhibitors (pIC~50~)   mazindol (p*K*~i~ 8.9), nisoxetine (p*K*~i~ 8.4), nomifensine (p*K*~i~ 8.1), reboxetine (p*K*~i~ 8.0) [@b205]   mazindol (p*K*~i~ 8.0), WIN35428 (p*K*~i~ 7.9), GBR12935 (p*K*~i~ 7.6)     paroxetine (p*K*~i~ 9.6) [@b198], sertraline (p*K*~i~ 9.1), fluoxetine (p*K*~i~ 8.5) [@b198]
  Radioligands (*K*~d~)            \[3H\]mazindol (5x10^-10^ M), \[3H\]nisoxetine (4x10^-9^ M)                                                     \[3H\]GBR12935 (3x10^-9^ M) [@b186], \[3H\]WIN35428 (1x10^-8^ M) [@b186]   \[3H\]paroxetine (2x10^-10^ M), \[3H\]citalopram (5x10^-9^ M)
  Stoichiometry                    1 noradrenaline: 1 Na^+^:1 Cl^-^ [@b171]                                                                        1 dopamine: 1--2 Na^+^: 1 Cl^-^ [@b170]                                    1 5-HT:1 Na^+^:1 Cl^-^ (in), + 1 K^+^ (out) [@b197]
  -------------------------------- --------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------

Comments
--------

\[125I\]RTI55 labels all three monoamine transporters (NET, DAT and SERT) with affinities between 0.5 and 5 nM. cocaine is an inhibitor of all three transporters with *p*K~i~ values between 6.5 and 7.2. Potential alternative splicing sites in non-coding regions of SERT and NET have been identified. A bacterial homologue of SERT shows allosteric modulation by selected anti-depressants [@b194].

GABA transporter subfamily
==========================

Overview
--------

The activity of GABA-transporters located predominantly upon neurones (GAT-1), glia (GAT-3) or both (GAT-2, BGT-1) serves to terminate phasic GABA-ergic transmission, maintain low ambient extracellular concentrations of GABA, and recycle GABA for reuse by neurones. Nonetheless, ambient concentrations of GABA are sufficient to sustain tonic inhibition mediated by high affinity GABA~A~ receptors in certain neuronal populations [@b192]. GAT1 is the predominant GABA transporter in the brain and occurs primarily upon the terminals of presynaptic neurones and to a much lesser extent upon distal astocytic processes that are in proximity to axons terminals. GAT3 resides predominantly on distal astrocytic terminals that are close to the GABAergic synapse. By contrast, BGT1 occupies an extrasynaptic location possibly along with GAT2 which has limited expression in the brain [@b181]. TauT is a high affinity taurine transporter involved in osmotic balance that occurs in the brain and non-neuronal tissues, such as the kidney, brush border membrane of the intestine and blood brain barrier [@b156],[@b172]. CT1, which transports creatine, has a ubiquitous expression pattern, often co-localizing with creatine kinase [@b156].

  -------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- -------------------------- -------------------------------------------------------------------------------------------------------------- ---------------------------------- -------------------------------------
  Nomenclature                     GAT1                                                                                                                                                                             GAT2                               GAT3                       BGT1                                                                                                           TauT                               CT1
  Systematic nomenclature          SLC6A1                                                                                                                                                                           SLC6A13                            SLC6A11                    SLC6A12                                                                                                        SLC6A6                             SLC6A8
  HGNC, UniProt                    SLC6A1, P30531                                                                                                                                                                   SLC6A13, Q9NSD5                    SLC6A11, P48066            SLC6A12, P48065                                                                                                SLC6A6, P31641                     SLC6A8, P48029
  Endogenous substrates            GABA                                                                                                                                                                             GABA, β-alanine                    GABA, β-alanine            GABA, betaine                                                                                                  GABA [@b145], β-alanine, taurine   creatine
  Substrates                       nipecotic acid, guvacine                                                                                                                                                         nipecotic acid, guvacine           nipecotic acid, guvacine   --                                                                                                             --                                 --
  Selective inhibitors (pIC~50~)   SKF89976A (6.9), CI-966 (6.6), NNC-711 (5.9 -- 6.9), tiagabine (5.6 -- 7.0), LU32-176B (5.4), (R/S) EF-1500 (4.9 -- 5.7), (R)-EF-1520 (5.05 -- 5.4), (S)-EF-1520 (3.6 -- 3.92)   SNAP-5114 (5.2), SNAP-5114 (4.7)   --                         NNC052090 (5.6), (R/S) EF-1500 (4.9), (R)-EF-1520 (3.74 -- 4.66), (S)-EF-1520 (3.6 -- 4.47), LU32-176B (4.0)   --                                 --
  Radioligands (*K*~d~)            \[3H\]tiagabine                                                                                                                                                                  --                                 --                         --                                                                                                             --                                 --
  Stoichiometry                    2Na^+^: 1Cl^-^: 1GABA                                                                                                                                                            2Na^+^: 1Cl^-^:1GABA               ≥ 2Na^+^: 2 Cl^-^: 1GABA   3Na^+^: 1 (or 2) Cl^-^: 1GABA                                                                                  2Na^+^: 1Cl^-^: 1 taurine          Probably 2Na^+^: 1Cl^-^: 1 creatine
  -------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- -------------------------- -------------------------------------------------------------------------------------------------------------- ---------------------------------- -------------------------------------

Comments
--------

The IC~50~ values for GAT1-4 reported in the table reflect the range reported in the literature from studies of both human and mouse transporters. There is a tendency towards lower IC~50~ values for the human orthologue [@b180]. SNAP-5114 is only weakly selective for GAT 2 and GAT3, with IC~50~ values in the range 22 to \>30 μM at GAT1 and BGT1, whereas NNC052090 has at least an order of magnitude selectivity for BGT1 \[see [@b157],[@b191] for reviews\]. (R)-(1-{2-\[tris(4-methoxyphenyl)methoxy\]ethyl}pyrrolidin-2-yl)acetic acid is a recently described compound that displays 20-fold selectivity for GAT3 over GAT1 [@b165]. In addition to the inhibitors listed, EGYT3886 is a moderately potent, though non-selective, inhibitor of all cloned GABA transporters (IC~50~ = 26-46 μM; [@b160]). Diaryloxime and diarylvinyl ether derivatives of nipecotic acid and guvacine that potently inhibit the uptake of \[3H\]GABA into rat synaptosomes have been described [@b178]. Several derivatives of exo-THPO (*e.g.* N-methyl-exo-THPO and N-acetyloxyethyl-exo-THPO) demonstrate selectivity as blockers of astroglial, versus neuronal, uptake of GABA \[see [@b157],[@b190] for reviews\]. GAT3 is inhibited by physiologically relevant concentrations of Zn^2+^ [@b158]. TauT transports GABA, but with low affinity, but CT1 does not, although it can be engineered to do so by mutagenesis guided by LeuT as a structural template [@b161]. Although inhibitors of creatine transport by CT1 (*e.g.* β-guanidinopropionic acid, cyclocreatine, guanidinoethane sulfonic acid) are known (*e.g*. [@b159]) they insufficiently characterized to be included in the table.

Glycine transporter subfamily
=============================

Overview
--------

Two gene products, GlyT1 and GlyT2, are known that give rise to transporters that are predominantly located on glia and neurones, respectively. Five variants of GlyT1 (a,b,c,d & e) differing in their N- and C-termini are generated by alternative promoter usage and splicing, and three splice variants of GlyT2 (a,b & c) have also been identified (see [@b148],[@b163],[@b167],[@b196] for reviews). GlyT1 transporter isoforms expressed in glia surrounding glutamatergic synapses regulate synaptic glycine concentrations influencing NMDA receptor-mediated neurotransmission [@b147],[@b166], but also are important, in early neonatal life, for regulating glycine concentrations at inhibitory glycinergic synapses [@b168]. Homozygous mice engineered to totally lack GlyT1 exhibit severe respiratory and motor deficiencies due to hyperactive glycinergic signalling and die within the first postnatal day [@b168],[@b199]. Disruption of GlyT1 restricted to forebrain neurones is associated with enhancement of EPSCs mediated by NMDA receptors and behaviours that are suggestive of a promnesic action [@b207]. GlyT2 transporters localised on the axons and boutons of glycinergic neurones appear crucial for efficient transmitter loading of synaptic vesicles but may not be essential for the termination of inhibitory neurotransmission [@b169],[@b188]. Mice in which GlyT2 has been deleted develop a fatal hyperekplexia phenotype during the second postnatal week [@b169] and mutations in the human gene encoding GlyT2 (SLC6A5) have been identified in patients with hyperekplexia (reviewed by [@b173]). ATB^0+^ (SLCA14) is a transporter for numerous dipolar and cationic amino acids and thus has a much broader substrate specificity than the glycine transporters alongside which it is grouped on the basis of structural similarity [@b156]. ATB^0+^ is expressed in various peripheral tissues [@b156]. By contrast PROT (SLC6A7), which is expressed only in brain in association with a subset of excitatory nerve terminals, shows specificity for the transport of L-proline.

  -------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------
  Nomenclature                     Glycine transporter 1                                                                                                                                                                                                  Glycine transporter 2                                                                                                                                                 ATB0,+                                                                                                                                  Proline transporter
  Systematic nomenclature          SLC6A9                                                                                                                                                                                                                 SLC6A5                                                                                                                                                                SLC6A14                                                                                                                                 SLC6A7
  Common abbreviation              GlyT1                                                                                                                                                                                                                  GlyT2                                                                                                                                                                 ATB^0,+^                                                                                                                                PROT
  HGNC, UniProt                    SLC6A9, P48067                                                                                                                                                                                                         SLC6A5, Q9Y345                                                                                                                                                        SLC6A14, Q9UN76                                                                                                                         SLC6A7, Q99884
  Endogenous substrates            glycine, sarcosine                                                                                                                                                                                                     glycine                                                                                                                                                               L-isoleucine \> L-leucine, L-methionine \> L-phenylalanine \> L-tryptophan \> L-valine \> L-serine [@b195], β-alanine [@b144],[@b145]   L-proline
  Substrates                       --                                                                                                                                                                                                                     --                                                                                                                                                                    1-methyltryptophan [@b177], BCH, valganciclovir [@b200], zwitterionic or cationic NOS inhibitors [@b174]                                --
  Selective inhibitors (pIC~50~)   (R)-NFPS (8.5 -- 9.1), SSR-103800 (8.7), N-methyl-SSR504734 (8.6), LY2365109 (7.8), GSK931145 (7.6)                                                                                                                    ALX 1393, ALX 1405, Org 25543 (7.7)                                                                                                                                   α-methyl-D,L-tryptophan (3.6) [@b177]                                                                                                   LP-403812 (7.0) [@b208]
  Radioligands (*K*~d~)            \[3H\](R)-NPTS (1x10^-9^ M), \[3H\]GSK931145 (1.7x10^-9^ M), \[35S\]ACPPB (2x10^-9^ M), \[3H\]SB-733993 (2.2x10^-9^ M), \[3H\]N-methyl-SSR504734 (3.3x10^-9^ -- 8.1x10^-9^ M), \[3H\]NFPS (7x10^-9^ -- 2.1x10^-8^ M)   --                                                                                                                                                                    --                                                                                                                                      --
  Stoichiometry                    2 Na^+^: 1 Cl^-^: 1 glycine                                                                                                                                                                                            3 Na^+^: 1 Cl^-^: 1 glycine                                                                                                                                           2-3 Na^+^: 1 Cl^-^: 1 amino acid [@b195]                                                                                                Probably 2 Na^+^: 1 Cl^-^: 1 L-proline
  Comment                          --                                                                                                                                                                                                                     N-Oleoyl-L-carnitine (0.3μM, [@b155]) and and N-arachidonoylglycine (IC~50~ 5-8 μM, [@b204]) have been described as potential endogenous selective GlyT2 inhibitors   --                                                                                                                                      --
  -------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------

Comments
--------

sarcosine is a selective transportable inhibitor of GlyT1 and also a weak agonist at the glycine binding site of the NMDA receptor [@b210], but has no effect on GlyT2. This difference has been attributed to a single glycine residue in TM6 (serine residue in GlyT2) [@b202]. Inhibition of GLYT1 by the sarcosine derivatives NFPS, NPTS and Org 24598 is non-competitive [@b182],[@b183]. IC~50~ values for Org 24598 reported in the literature vary, most likely due to differences in assay conditions [@b149],[@b182]. The tricyclic antidepressant amoxapine weakly inhibits GlyT2 (IC~50~ 92 μM) with approximately 10-fold selectivity over GlyT1 [@b184]. The endogenous lipids arachidonic acid and anandamide exert opposing effects upon GlyT1a, inhibiting (IC~50~ ∼ 2 μM) and potentiating (EC~50~ ∼ 13 μM) transport currents, respectively [@b185]. N-arachidonyl-glycine, N-arachidonyl-γ-aminobutyric acid and N-arachidonyl-D-alanine have been described as endogenous non-competitive inhibitors of GlyT2a, but not GlyT1b [@b162],[@b175],[@b204]. Protons [@b146] and Zn^2+^ [@b176] act as non-competitive inhibitors of GlyT1b, with IC~50~ values of ∼100 nM and ∼10 μM respectively, but neither ion affects GlyT2 (reviewed by [@b201]). Glycine transport by GLYT1 is inhibited by lithium, whereas GLYT2 transport is stimulated (both in the presence of Na^+^) [@b187].

Neutral amino acid transporter subfamily
========================================

Overview
--------

Certain members of neutral amino acid transport family are expressed upon the apical surface of epithelial cells and are important for the absorption of amino acids from the duodenum, jejunum and ileum and their reabsorption within the proximal tubule of the nephron (*i.e.* B^0^AT1 (SLC6A19), SLC6A17, SLC6A18, SLC6A20). Others may function as transporters for neurotransmitters or their precursors (*i.e.* B^0^AT2, SLC6A17) [@b153].

  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ----------------- -------------------------------------------------------------------------------------------------------------------- ----------------------------------------
  Nomenclature              B0AT1                                                                                                                                              B0AT2                                                                                                                                                B0AT3                                                                                              NTT5              NTT4                                                                                                                 SIT1
  Systematic nomenclature   SLC6A19                                                                                                                                            SLC6A15                                                                                                                                              SLC6A18                                                                                            SLC6A16           SLC6A17                                                                                                              SLC6A20
  HGNC, UniProt             SLC6A19, Q695T7                                                                                                                                    SLC6A15, Q9H2J7                                                                                                                                      SLC6A18, Q96N87                                                                                    SLC6A16, Q9GZN6   SLC6A17, Q9H1V8                                                                                                      SLC6A20, Q9NP91
  Endogenous substrates     L-leucine, L-methionine, L-isoleucine, L-valine \> L-asparagine, L-phenylalanine, L-alanine, L-serine \> L-threonine, glycine, L-proline [@b152]   L-proline \> L-alanine, L-valine, L-methionine, L-leucine \> L-isoleucine, L-threonine, L-asparagine, L-serine, L-phenylalanine \> glycine [@b152]   L-alanine, glycine \> L-methionine, L-phenylalanine, L-leucine, L-histidine, L-glutamine [@b203]   --                L-leucine, L-methionine, L-proline \> L-cysteine, L-alanine, L-glutamine, L-serine \> L-histidine, glycine [@b209]   L-proline
  Stoichiometry             1 Na^+^: 1 amino acid [@b154]                                                                                                                      1 Na^+^: 1 amino acid [@b151]                                                                                                                        Na^+^- and Cl^-^ -dependent transport [@b193]                                                      --                Na^+^-dependent, Cl^-^-independent transport [@b209]                                                                 2 Na^+^: 1 Cl^-^: 1 imino acid [@b150]
  Comment                   Mutations in B^0^AT1 are associated with Hartnup disorder                                                                                          --                                                                                                                                                   --                                                                                                 --                --                                                                                                                   --
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ----------------- -------------------------------------------------------------------------------------------------------------------- ----------------------------------------

SLC8 family of sodium/calcium exchangers
========================================

Overview
--------

The sodium/calcium exchangers (NCX) use the extracellular sodium concentration to facilitate the extrusion of calcium out of the cell. Alongside the plasma membrane Ca^2+^-ATPase (PMCA) and sarcoplasmic/endoplasmic reticulum Ca^2+^-ATPase (SERCA), as well as the sodium/potassium/calcium exchangers (NKCX, SLC24 family), NCX allow recovery of intracellular calcium back to basal levels after cellular stimulation. When intracellular sodium ion levels rise, for example, following depolarisation, these transporters can operate in the reverse direction to allow calcium influx and sodium efflux, as an electrogenic mechanism. Structural modelling suggests the presence of 9 TM segments, with a large intracellular loop between the fifth and sixth TM segments.

  ------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------------- ----------------------------
  Nomenclature              Sodium/calcium exchanger 1                                                                                        Sodium/calcium exchanger 2   Sodium/calcium exchanger 3
  Systematic nomenclature   SLC8A1                                                                                                            SLC8A2                       SLC8A3
  Common abbreviation       NCX1                                                                                                              NCX2                         NCX3
  HGNC, UniProt             SLC8A1, P32418                                                                                                    SLC8A2, Q9UPR5               SLC8A3, P57103
  Stoichiometry             3 Na^+^ (in): 1 Ca^2+^ (out) or 4 Na^+^ (in): 1 Ca^2+^ (out) [@b211]; Reverse mode 1 Ca^2+^ (in): 1 Na^+^ (out)   --                           --
  ------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------------- ----------------------------

Comments
========

Although subtype-selective inhibitors of NCX function are not widely available, 3,4--dichlorobenzamil and CBDMB act as non-selective NCX inhibitors, while SEA0400, KB-R7943, SN6 and ORM-10103 [@b212] act to inhibit NCX function selectively.

SLC9 family of sodium/hydrogen exchangers
=========================================

Overview
--------

Sodium/hydrogen exchangers or sodium/proton antiports are a family of transporters that maintain cellular pH by utilising the sodium gradient across the plasma membrane to extrude protons produced by metabolism, in a stoichiometry of 1 Na^+^ (in): 1 H^+^ (out). Several isoforms, NHE6, NHE7, NHE8 and NHE9 appear to locate on intracellular membranes [@b215]--[@b217]. Li^+^ and NH~4~^+^, but not K^+^, ions may also be transported by some isoforms. Modelling of the topology of these transporters indicates 12 TM regions with an extended intracellular C-terminus containing multiple regulatory sites.

NHE1 is considered to be a ubiquitously-expressed 'housekeeping' transporter. NHE3 is highly expressed in the intestine and kidneys and regulate sodium movements in those tissues. NHE10 is present in sperm [@b220] and osteoclasts [@b214]; gene disruption results in infertile male mice [@b220].

  ----------------------------------------------------------------------------------- ------------------------- --------------------- ----------------
  Nomenclature                                                                        Systematic nomenclature   Common abbreviation   HGNC, UniProt
  Sodium/hydrogen exchanger 1                                                         SLC9A1                    NHE1                  SLC9A1, P19634
  Sodium/hydrogen exchanger 2                                                         SLC9A2                    NHE2                  SLC9A2, Q9UBY0
  Sodium/hydrogen exchanger 3                                                         SLC9A3                    NHE3                  SLC9A3, P48764
  Sodium/hydrogen exchanger 4                                                         SLC9A4                    NHE4                  SLC9A4, Q6AI14
  Sodium/hydrogen exchanger 5                                                         SLC9A5                    NHE5                  SLC9A5, Q14940
  Sodium/hydrogen exchanger 6                                                         SLC9A6                    NHE6                  SLC9A6, Q92581
  Sodium/hydrogen exchanger 7                                                         SLC9A7                    NHE7                  SLC9A7, Q96T83
  Sodium/hydrogen exchanger 8                                                         SLC9A8                    NHE8                  SLC9A8, Q9Y2E8
  Sodium/hydrogen exchanger 9                                                         SLC9A9                    NHE9                  SLC9A9, Q8IVB4
  solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1   SLC9B1                    NHA1                  SLC9B1, Q4ZJI4
  solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2   SLC9B2                    NHA2                  SLC9B2, Q86UD5
  Sodium/hydrogen exchanger 10                                                        SLC9C1                    Sperm-NHE             SLC9C1, Q4G0N8
  Sodium/hydrogen exchanger 11                                                        SLC9C2                    NHE11                 SLC9C2, Q5TAH2
  ----------------------------------------------------------------------------------- ------------------------- --------------------- ----------------

Comments
========

Analogues of the non-selective cation transport inhibitor amiloride appear to inhibit NHE function through competitive inhibition of the extracellular Na^+^ binding site. The more selective amiloride analogues MPA and EIPA exhibit a rank order of affinity of inhibition of NHE1 \> NHE2 \> NHE3 [@b213],[@b218],[@b219].

SLC10 family of sodium-bile acid co-transporters
================================================

Overview
--------

The SLC10 family transport bile acids, sulphated solutes, and other xenobiotics in a sodium-dependent manner. The founding members, SLC10A1 (NTCP) and SLC10A2 (ASBT) function, along with members of the ABC transporter family (MDR1/ABCB1, BSEP/ABCB11 and MRP2/ABCC2) and the organic solute transporter obligate heterodimer OSTα:OSTβ (SLC51), to maintain the enterohepatic circulation of bile acids [@b225],[@b234]. SLC10A6 (SOAT) functions as a sodium-dependent transporter of sulphated solutes included sulfphated steroids and bile acids [@b228],[@b230]. Transport function has not yet been demonstrated for the 4 remaining members of the SLC10 family, SLC10A3 (P3), SLC10A4 (P4), SLC10A5 (P5), and SLC10A7 (P7), and the identity of their endogenous substrates remain unknown [@b227],[@b230],[@b231],[@b237]. Members of the SLC10 family are predicted to have seven transmembrane domains with an extracellular N-terminus and cytoplasmic C-terminus [@b221],[@b232].

  ------------------------- ------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------
  Nomenclature              Sodium/bile acid and sulphated solute cotransporter 1                                                        Sodium/bile acid and sulphated solute cotransporter 2            Sodium/bile acid and sulphated solute cotransporter 6
  Systematic nomenclature   SLC10A1                                                                                                      SLC10A2                                                          SLC10A6
  Common abbreviation       NTCP                                                                                                         ASBT                                                             SOAT
  HGNC, UniProt             SLC10A1, Q14973                                                                                              SLC10A2, Q12908                                                  SLC10A6, Q3KNW5
  Substrates                tauroursodeoxycholic acid, taurocholic acid, taurochenodeoxycholic acid \> GCA \> cholic acid [@b235]        GDCA \> GUDCA, GCDA \> taurocholic acid \> cholic acid [@b224]   pregnenolone sulphate [@b228], dehydroepiandrosterone sulphate [@b230], taurolithocholic acid-3-sulphate, estrone-3-sulphate
  Endogenous substrates     T3, dehydroepiandrosterone sulphate [@b224],[@b227],[@b235], estrone-3-sulphate, iodothyronine sulphates     --                                                               --
  Radioligands (*K*~d~)     --                                                                                                           \[3H\]taurocholic acid [@b224]                                   --
  Stoichiometry             2 Na^+^: 1 bile acid [@b221],[@b228]                                                                         \>1 Na^+^: 1 bile acid [@b224],[@b238]                           --
  Comment                   chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine is a fluorescent bile acid analogue used as a probe [@b229].   --                                                               --
  Inhibitors (pIC~50~)      cyclosporin A [@b226],[@b233], irbesartan [@b226], propranolol [@b224]                                       SC-435 (8.82) [@b222], 264W94 (7.32) [@b236],[@b239]             --
  ------------------------- ------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------

  ------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  Nomenclature              Sodium/bile acid and sulphated solute cotransporter 3   Sodium/bile acid and sulphated solute cotransporter 4   Sodium/bile acid and sulphated solute cotransporter 5   Sodium/bile acid and sulphated solute cotransporter 7
  Systematic nomenclature   SLC10A3                                                 SLC10A4                                                 SLC10A5                                                 SLC10A7
  Common abbreviation       P3                                                      P4                                                      P5                                                      P7
  HGNC, UniProt             SLC10A3, P09131                                         SLC10A4, Q96EP9                                         SLC10A5, Q5PT55                                         SLC10A7, Q0GE19
  ------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------

Comments
========

Heterologously expressed SLC10A4 [@b229] or SLC10A7 [@b231] failed to exhibit significant transport of taurocholic acid, pregnenolone sulphate, DHEAS or choline. SLC10A4 has recently been suggested to associate with neuronal vesicles [@b223].

SLC11 family of proton-coupled metal ion transporters
=====================================================

Overview
--------

The family of proton-coupled metal ion transporters are responsible for movements of divalent cations, particularly ferrous and manganese ions, across the cell membrane (SLC11A2/DMT1) and across endosomal (SLC11A2/DMT1) or lysosomal/phagosomal membranes (SLC11A1/NRAMP1), dependent on proton transport. Both proteins appear to have 12 TM regions and cytoplasmic N- and C- termini. NRAMP1 is involved in antimicrobial action in macrophages, although its precise mechanism is undefined. Facilitated diffusion of divalent cations into phagosomes may increase intravesicular free radicals to damage the pathogen. Alternatively, export of divalent cations from the phagosome may deprive the pathogen of essential enzyme cofactors. SLC11A1/DMT1 is more widely expressed and appears to assist in divalent cation assimilation from the diet, as well as in phagocytotic cells.

  ------------------------- ------------------------------------------------------- ------------------------------------
  Nomenclature              NRAMP1                                                  DMT1
  Systematic nomenclature   SLC11A1                                                 SLC11A2
  HGNC, UniProt             SLC11A1, P49279                                         SLC11A2, P49281
  Endogenous substrates     Fe^2+^, Mn^2+^                                          Cd2+, Co^2+^, Cu2+, Fe^2+^, Mn^2+^
  Stoichiometry             1 H^+^: 1 Fe^2+^ (out) or 1 Fe^2+^ (in): 1 H^+^ (out)   1 H^+^: 1 Fe^2+^ (out) [@b240]
  ------------------------- ------------------------------------------------------- ------------------------------------

Comments
========

Loss-of-function mutations in NRAMP1 are associated with increased susceptibility to microbial infection (OMIM: 607948). Loss-of-function mutations in DMT1 are associated with microcytic anemia (OMIM: 206100).

SLC12 family of cation-coupled chloride transporters
====================================================

Overview
--------

The SLC12 family of chloride transporters contribute to ion fluxes across a variety of tissues, particularly in the kidney and choroid plexus of the brain. Within this family, further subfamilies are identifiable: NKCC1, NKCC2 and NCC constitute a group of therapeutically-relevant transporters, targets for loop and thiazide diuretics. These 12 TM proteins exhibit cytoplasmic termini and an extended extracellular loop at TM7/8 and are kidney-specific (NKCC2 and NCC) or show a more widespread distribution (NKCC1). A second family, the K-Cl co-transporters are also 12 TM domain proteins with cytoplasmic termini, but with an extended extracellular loop at TM 5/6. CCC6 exhibits structural similarities with the K-Cl co-transporters, while CCC9 is divergent, with 11 TM domains and a cytoplasmic N-terminus and extracellular C-terminus.

  ------------------------- ------------------------------------------------------------ ------------------------------------------------------------ -------------------------------------------------
  Nomenclature              Kidney-specific Na-K-Cl symporter                            Basolateral Na-K-Cl symporter                                Na-Cl symporter
  Systematic nomenclature   SLC12A1                                                      SLC12A2                                                      SLC12A3
  Common abbreviation       NKCC2                                                        NKCC1                                                        NCC
  HGNC, UniProt             SLC12A1, Q13621                                              SLC12A2, P55011                                              SLC12A3, P55017
  Inhibitors (pIC~50~)      bumetanide [@b242], furosemide [@b242], piretanide [@b242]   bumetanide [@b242], furosemide [@b242], piretanide [@b242]   chlorothiazide, hydrochlorothiazide, metolazone
  Stoichiometry             1 Na^+^: 1 K^+^: 2 Cl^-^ (in)                                1 Na^+^: 1 K^+^: 2 Cl^-^ (in)                                1 Na^+^: 1 Cl^-^ (in)
  ------------------------- ------------------------------------------------------------ ------------------------------------------------------------ -------------------------------------------------

  ------------------------- ----------------------- ------------------------- ----------------------- -----------------------
  Nomenclature              K-Cl cotransporter 1    K-Cl cotransporter 2      K-Cl cotransporter 3    K-Cl cotransporter 4
  Systematic nomenclature   SLC12A4                 SLC12A5                   SLC12A6                 SLC12A7
  Common abbreviation       KCC1                    KCC2                      KCC3                    KCC4
  HGNC, UniProt             SLC12A4, Q9UP95         SLC12A5, Q9H2X9           SLC12A6, Q9UHW9         SLC12A7, Q9Y666
  Inhibitors (pIC~50~)      DIOA                    DIOA, VU0240551 [@b241]   DIOA                    DIOA
  Stoichiometry             1 K^+^: 1 Cl^-^ (out)   1 K^+^: 1 Cl^-^ (out)     1 K^+^: 1 Cl^-^ (out)   1 K^+^: 1 Cl^-^ (out)
  ------------------------- ----------------------- ------------------------- ----------------------- -----------------------

  ------------------------- -------------------------------------------------------- -------------------------------------------
  Nomenclature              Cation-chloride cotransporter 9                          Cation-chloride cotransporter 6
  Systematic nomenclature   SLC12A8                                                  SLC12A9
  Common abbreviation       CCC9                                                     CCC6
  HGNC, UniProt             SLC12A8, A0AV02                                          SLC12A9, Q9BXP2
  Substrates                spermine, L-glutamic acid, spermidine, L-aspartic acid   --
  Stoichiometry             Unknown                                                  --
  Comment                   --                                                       CCC6 is regarded as an orphan transporter
  ------------------------- -------------------------------------------------------- -------------------------------------------

Comments
========

DIOA is able to differentiate KCC isoforms from NKCC and NCC transporters, but also inhibits CFTR [@b243].

SLC13 family of sodium-dependent sulphate/carboxylate transporters
==================================================================

Overview
--------

Within the SLC13 family, two groups of transporters may be differentiated on the basis of the substrates transported: NaS1 and NaS2 convey sulphate, while NaC1-3 transport carboxylates. NaS1 and NaS2 transporters are made up of 13 TM domains, with an intracellular N terminus and are electrogenic with physiological roles in the intestine, kidney and placenta. NaC1, NaC2 and NaC3 are made up of 11 TM domains with an intracellular N terminus and are electrogenic, with physiological roles in the kidney and liver.

  ------------------------- --------------------------- ----------------------------------- ----------------------------------- --------------------------- ---------------------------
  Nomenclature              Na+/sulfate cotransporter   Na+/dicarboxylate cotransporter 1   Na+/dicarboxylate cotransporter 3   Na+/sulfate cotransporter   Na+/citrate cotransporter
  Systematic nomenclature   SLC13A1                     SLC13A2                             SLC13A3                             SLC13A4                     SLC13A5
  Common abbreviation       NaS1                        NaC1                                NaC3                                NaS2                        NaC2
  HGNC, UniProt             SLC13A1, Q9BZW2             SLC13A2, Q13183                     SLC13A3, Q8WWT9                     SLC13A4, Q9UKG4             SLC13A5, Q86YT5
  Endogenous substrates     SeO42-, S2O32-, SO42-       citric acid, succinic acid          citric acid, succinic acid          SO42-                       citric acid, pyruvic acid
  Stoichiometry             3 Na^+^: 1 SO~4~^2-^ (in)   3 Na^+^: 1 dicarboxylate^2-^ (in)   Unknown                             3 Na^+^: SO~4~^2-^ (in)     Unknown
  ------------------------- --------------------------- ----------------------------------- ----------------------------------- --------------------------- ---------------------------

SLC14 family of facilitative urea transporters
==============================================

Overview
--------

As a product of protein catabolism, urea is moved around the body and through the kidneys for excretion. Although there is experimental evidence for concentrative urea transporters, these have not been defined at the molecular level. The SLC14 family are facilitative transporters, allowing urea movement down its concentration gradient. Multiple splice variants of these transporters have been identified; for UT-A transporters, in particular, there is evidence for cell-specific expression of these variants with functional impact [@b245]. Topographical modelling suggests that the majority of the variants of SLC14 transporters have 10 TM domains, with a glycosylated extracellular loop at TM5/6, and intracellular C- and N-termini. The UT-A1 splice variant, exceptionally, has 20 TM domains, equivalent to a combination of the UT-A2 and UT-A3 splice variants.

  ------------------------- ------------------------------------------------------------- -------------------------
  Nomenclature              Erythrocyte urea transporter                                  Kidney urea transporter
  Systematic nomenclature   SLC14A1                                                       SLC14A2
  Common abbreviation       UT-B                                                          UT-A
  HGNC, UniProt             SLC14A1, Q13336                                               SLC14A2, Q15849
  Endogenous substrates     ammonium carbonate [@b246], urea [@b246], formamide [@b246]   urea [@b244]
  Substrates                acrylamide [@b246], acetamide [@b246], methylurea [@b246]     --
  Stoichiometry             Equilibrative                                                 Equilibrative
  ------------------------- ------------------------------------------------------------- -------------------------

SLC15 family of peptide transporters
====================================

Overview
--------

The SLC15 family of peptide transporters may be divided on the basis of structural and functional differences into two subfamilies: SLC15A1 (PepT1) and SLC15A2 (PepT2) transport di- and tripeptides, but not amino acids, whereas SLC15A3 (PHT2) and SLC15A4 (PHT1) transport L-histidine and some di- and tripeptides [@b251]. The transporters are 12 TM proteins with intracellular termini and an extended extracellular loop at TM 9/10. The crystal structure of PepTSo (a prokaryote homologue of PepT1 and PepT2 from *Shewanella oneidensis*) confirms many of the predicted structural features of mammalian PepT1 and PepT2 [@b261].

PHT1 has been suggested to be intracellular [@b262], while PHT2 protein is located on lysosomes in transfected cells [@b250],[@b257],[@b264]. PHT1 is hypothesised to mediate efflux of bacterial-derived peptides into the cytosol perhaps in the colon where SLC15A4 mRNA expression is increased in inflammatory bowel disease [@b259]. Transport via PHT1 may be important in immune responses as both Toll-like receptor- and NOD1-mediated responses are reduced in PHT1 knockout mice or mouse strains expressing mutations in PHT1 [@b249],[@b265].

  ------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------- -------------------------------------------------
  Nomenclature              Peptide transporter 1                                                                                            Peptide transporter 2                                            Peptide transporter 3                             Peptide transporter 4
  Systematic nomenclature   SLC15A1                                                                                                          SLC15A2                                                          SLC15A3                                           SLC15A4
  Common abbreviation       PepT1                                                                                                            PepT2                                                            PHT2                                              PHT1
  HGNC, UniProt             SLC15A1, P46059                                                                                                  SLC15A2, Q16348                                                  SLC15A3, Q8IY34                                   SLC15A4, Q8N697
  Endogenous substrates     5-aminolevulinic acid [@b253], dipeptides [@b253], tripeptides [@b253]                                           5-aminolevulinic acid, dipeptides, tripeptides                   L-histidine, carnosine, dipeptides, tripeptides   L-histidine, carnosine, dipeptides, tripeptides
  Substrates                fMet-Leu-Phe [@b260], cyclacillin [@b254], valacyclovir [@b255], cefadroxil [@b254], muramyl dipeptide [@b268]   cyclacillin [@b254], cefadroxil [@b254]                          --                                                valacyclovir [@b247]
  Inhibitors (pIC~50~)      4-AMBA [@b252], Lys\[Z(NO2)\]-Pro [@b258]                                                                        Lys\[Z(NO2)\]-Lys\[Z(NO2)\] [@b248],[@b267], Lys\[Z(NO2)\]-Pro   --                                                --
  Radioligands (*K*~d~)     \[11C\]GlySar, \[14C\]GlySar, \[3H\]GlySar                                                                       \[11C\]GlySar, \[14C\]GlySar, \[3H\]GlySar                       \[14C\]histidine, \[3H\]histidine                 \[14C\]histidine, \[3H\]histidine
  Stoichiometry             1 H^+^: 1 zwitterionic peptide (in)                                                                              2 H^+^: 1 zwitterionic peptide (in)                              Unknown                                           Unknown
  ------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------- -------------------------------------------------

Comments
========

The PepT1 and PepT2 transporters are particularly promiscuous in the transport of dipeptides and tripeptides from the endogenous amino acids, as well as some D-amino acid containing peptides. PepT1 has also been exploited to allow delivery of therapeutic pro-drugs, such as those for zidovudine [@b256], sulpiride [@b269] and cytarabine [@b266].

D-Ala-Lys-AMCA has been used as a fluorescent probe to identify transport via both PepT1 and PepT2 [@b263].

SLC16 family of monocarboxylate transporters
============================================

Overview
--------

Members of the SLC16 family may be divided into subfamilies on the basis of substrate selectivities, particularly lactate (*e.g.* L-lactic acid), pyruvic acid and ketone bodies, as well as aromatic amino acids. Topology modelling suggests 12 TM domains, with intracellular termini and an extended loop at TM 6/7.

The proton-coupled monocarboxylate transporters (monocarboxylate transporters 1, 4, 2 and 3) allow transport of the products of cellular metabolism, principally lactate (*e.g.* L-lactic acid) and pyruvic acid.

  ------------------------- ------------------------------------------------------ ------------------------------------ ------------------------------------ ------------------------------------
  Nomenclature              Monocarboxylate transporter 1                          Monocarboxylate transporter 4        Monocarboxylate transporter 2        Monocarboxylate transporter 3
  Systematic nomenclature   SLC16A1                                                SLC16A3                              SLC16A7                              SLC16A8
  Common abbreviation       MCT1                                                   MCT4                                 MCT2                                 MCT3
  HGNC, UniProt             SLC16A1, P53985                                        SLC16A3, O15427                      SLC16A7, O60669                      SLC16A8, O95907
  Endogenous substrates     β-D-hydroxybutyric acid, L-lactic acid, pyruvic acid   L-lactic acid, pyruvic acid          L-lactic acid, pyruvic acid          L-lactic acid
  Substrates                γ-hydroxybutyric acid [@b272]                          --                                   --                                   --
  Stoichiometry             1 H^+^: 1 monocarboxylate^-^ (out)                     1 H^+^: 1 monocarboxylate^-^ (out)   1 H^+^: 1 monocarboxylate^-^ (out)   1 H^+^: 1 monocarboxylate^-^ (out)
  ------------------------- ------------------------------------------------------ ------------------------------------ ------------------------------------ ------------------------------------

  ------------------------- ------------------------------- ---------------------------------------------------
  Nomenclature              Monocarboxylate transporter 8   Monocarboxylate transporter 10
  Systematic nomenclature   SLC16A2                         SLC16A10
  Common abbreviation       MCT8                            TAT1
  HGNC, UniProt             SLC16A2, P36021                 SLC16A10, Q8TF71
  Endogenous substrates     T3 [@b270], T4 [@b270]          L-tryptophan, L-phenylalanine, L-DOPA, L-tyrosine
  Stoichiometry             Unknown                         Unknown
  ------------------------- ------------------------------- ---------------------------------------------------

  ------------------------- ------------------------------- ----------------------------------------------------------------------------------------- ------------------------------- ------------------------------- -------------------------------- -------------------------------- -------------------------------- --------------------------------
  Nomenclature              Monocarboxylate transporter 5   Monocarboxylate transporter 6                                                             Monocarboxylate transporter 7   Monocarboxylate transporter 9   Monocarboxylate transporter 11   Monocarboxylate transporter 12   Monocarboxylate transporter 13   Monocarboxylate transporter 14
  Systematic nomenclature   SLC16A4                         SLC16A5                                                                                   SLC16A6                         SLC16A9                         SLC16A11                         SLC16A12                         SLC16A13                         SLC16A14
  Common abbreviation       MCT5                            MCT6                                                                                      MCT7                            MCT9                            MCT11                            MCT12                            MCT13                            MCT14
  HGNC, UniProt             SLC16A4, O15374                 SLC16A5, O15375                                                                           SLC16A6, O15403                 SLC16A9, Q7RTY1                 SLC16A11, Q8NCK7                 SLC16A12, Q6ZSM3                 SLC16A13, Q7RTY0                 SLC16A14, Q7RTX9
  Stoichiometry             Unknown                         Unknown                                                                                   Unknown                         Unknown                         Unknown                          Unknown                          Unknown                          Unknown
  Comment                   --                              MCT6 has been reported to transport bumetanide, but not short chain fatty acids [@b271]   --                              --                              --                               --                               --                               --
  ------------------------- ------------------------------- ----------------------------------------------------------------------------------------- ------------------------------- ------------------------------- -------------------------------- -------------------------------- -------------------------------- --------------------------------

Comments
========

MCT1 and MCT2, but not MCT3 and MCT4, are inhibited by CHC, which also inhibits members of the mitochondrial transporter family, SLC25.

MCT5-MCT7, MCT9 and MCT11-14 are regarded as orphan transporters.

SLC17 phosphate and organic anion transporter family
====================================================

Overview
--------

The SLC17 family are sometimes referred to as Type I sodium-phosphate co-transporters, alongside Type II (SLC34 family) and Type III (SLC20 family) transporters. Within the SLC17 family, however, further subgroups of organic anion transporters may be defined, allowing the accumulation of sialic acid in the endoplasmic reticulum and glutamate (*e.g.* L-glutamic acid) or nucleotides in synaptic and secretory vesicles. Topology modelling suggests 12 TM domains.

Type I sodium-phosphate co-transporters
=======================================

Overview
--------

Type I sodium-phosphate co-transporters are expressed in the kidney and intestine.

  ------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------------
  Nomenclature              Sodium/phosphate cotransporter 1                                                                                 Sodium/phosphate cotransporter 3   Sodium/phosphate cotransporter 4   Sodium/phosphate cotransporter homolog
  Systematic nomenclature   SLC17A1                                                                                                          SLC17A2                            SLC17A3                            SLC17A4
  Common abbreviation       NPT1                                                                                                             NPT3                               NPT4                               --
  HGNC, UniProt             SLC17A1, Q14916                                                                                                  SLC17A2, O00624                    SLC17A3, O00476                    SLC17A4, Q9Y2C5
  Substrates                Cl- [@b275], probenecid [@b274], PO34- [@b275], uric acid [@b275], penicillin G [@b274], organic acids [@b275]   --                                 --                                 --
  Stoichiometry             Unknown                                                                                                          Unknown                            Unknown                            Unknown
  ------------------------- ---------------------------------------------------------------------------------------------------------------- ---------------------------------- ---------------------------------- ----------------------------------------

Sialic acid transporter
=======================

Overview
--------

The sialic acid transporter is expressed on both lysosomes and synaptic vesicles, where it appears to allow export of sialic acid and accumulation of acidic amino acids, respectively [@b277], driven by proton gradients. In lysosomes, degradation of glycoproteins generates amino acids and sugar residues, which are metabolized further following export from the lysosome.

  ------------------------- ---------------------------------------------------------------------------------------------------------------------
  Nomenclature              Sialin
  Systematic nomenclature   SLC17A5
  Common abbreviation       AST
  HGNC, UniProt             SLC17A5, Q9NRA2
  Endogenous substrates     L-glutamic acid (in) [@b277], L-lactic acid, L-aspartic acid [@b277], gluconate (out), sialic acid, glucuronic acid
  Stoichiometry             1 H^+^: 1 sialic acid (out)
  ------------------------- ---------------------------------------------------------------------------------------------------------------------

Comments
--------

Loss-of-function mutations in sialin are associated with Salla disease (OMIM: 604369), an autosomal recessive neurodegenerative disorder associated with sialic acid storage disease [@b279].

Vesicular glutamate transporters (VGLUTs)
=========================================

Overview
--------

Vesicular glutamate transporters (VGLUTs) allow accumulation of glutamate into synaptic vesicles, as well as secretory vesicles in endocrine tissues. The roles of VGLUTs in kidney and liver are unclear. These transporters appear to utilize the proton gradient and also express a chloride conductance [@b273].

  ------------------------- ------------------------------------ ------------------------------------ ------------------------------------
  Nomenclature              Vesicular glutamate transporter 1    Vesicular glutamate transporter 2    Vesicular glutamate transporter 3
  Systematic nomenclature   SLC17A7                              SLC17A6                              SLC17A8
  Common abbreviation       VGLUT1                               VGLUT2                               VGLUT3
  HGNC, UniProt             SLC17A7, Q9P2U7                      SLC17A6, Q9P2U8                      SLC17A8, Q8NDX2
  Endogenous substrates     L-glutamic acid \> D-glutamic acid   L-glutamic acid \> D-glutamic acid   L-glutamic acid \> D-glutamic acid
  Stoichiometry             Unknown                              Unknown                              Unknown
  ------------------------- ------------------------------------ ------------------------------------ ------------------------------------

Comments
--------

Endogenous ketoacids produced during fasting have been proposed to regulate VGLUT function through blocking chloride ion-mediated allosteric enhancement of transporter function [@b276].

Vesicular nucleotide transporter
================================

Overview
--------

The vesicular nucleotide transporter is the most recent member of the SLC17 family to have an assigned function. Uptake of ATP was independent of pH, but dependent on chloride ions and membrane potential [@b278].

  ------------------------- ---------------------------------------
  Nomenclature              Vesicular nucleotide transporter
  Systematic nomenclature   SLC17A9
  Common abbreviation       VNUT
  HGNC, UniProt             SLC17A9, Q9BYT1
  Endogenous substrates     ATP [@b278], GTP [@b278], GDP [@b278]
  Stoichiometry             Unknown
  ------------------------- ---------------------------------------

Comments
--------

VGLUTs and VNUT can be inhibited by DIDS and evans blue dye.

SLC18 family of vesicular amine transporters
============================================

Overview
--------

The vesicular amine transporters (VATs) are putative 12 TM domain proteins that function to transport singly positively charged amine neurotransmitters and hormones from the cytoplasm and concentrate them within secretory vesicles. They function as amine/proton antiporters driven by secondary active transport utilizing the proton gradient established by a multi-subunit vacuolar ATPase that acidifies secretory vesicles (reviewed by [@b283]). The vesicular acetylcholine transporter (VAChT; [@b287]) localizes to cholinergic neurons, but non-neuronal expression has also been claimed [@b290]. Vesicular monoamine transporter 1 (VMAT1, [@b285]) is mainly expressed in peripheral neuroendocrine cells, but most likely not in the CNS, whereas VMAT2 [@b286] distributes between both central and peripheral sympathetic monoaminergic neurones [@b284].

  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------
  Nomenclature              Vesicular monoamine transporter 1                                                                                                                                                                   Vesicular monoamine transporter 2                                                                                                                                                                   Vesicular acetylcholine transporter                                                                                                       solute carrier family 18, subfamily B, member 1
  Systematic nomenclature   SLC18A1                                                                                                                                                                                             SLC18A2                                                                                                                                                                                             SLC18A3                                                                                                                                   SLC18B1
  Common abbreviation       VMAT1                                                                                                                                                                                               VMAT2                                                                                                                                                                                               VAChT                                                                                                                                     --
  HGNC, UniProt             SLC18A1, P54219                                                                                                                                                                                     SLC18A2, Q05940                                                                                                                                                                                     SLC18A3, Q16572                                                                                                                           SLC18B1, Q6NT16
  Endogenous substrates     5-HT (Ki 1.4x10^-6^ M) [@b286], (-)-adrenaline (Ki 5.5x10^-6^ M) [@b286], (-)-noradrenaline (Ki 1.37x10^-5^ M) [@b286], dopamine (Ki 3.8x10^-6^ M) [@b286], histamine (Ki 4.696x10^-3^ M) [@b286]   5-HT (Ki 9x10^-7^ M) [@b286], (-)-adrenaline (Ki 1.9x10^-6^ M) [@b286], (-)-noradrenaline (Ki 3.4x10^-6^ M) [@b286], dopamine (Ki 1.4x10^-6^ M) [@b286], histamine (Ki 1.43x10^-4^ M) [@b286]       acetylcholine (Ki 7.94x10^-4^ M) [@b280],[@b288], choline (Ki 5x10^-4^ M) [@b280],[@b288]                                                 --
  Substrates                β-phenylethylamine (Ki 3.4x10^-5^ M) [@b286], dextroamphetamine (Ki 4.7x10^-5^ M) [@b286], MPP+ (Ki 6.9x10^-5^ M) [@b286], MDMA (Ki 1.9x10^-5^ M) [@b286], fenfluramine (Ki 3.1x10^-6^ M) [@b286]   β-phenylethylamine (Ki 3.7x10^-6^ M) [@b286], dextroamphetamine (Ki 2.1x10^-6^ M) [@b286], MPP+ (Ki 8.9x10^-6^ M) [@b286], MDMA (Ki 6.9x10^-6^ M) [@b286], fenfluramine (Ki 5.1x10^-6^ M) [@b286]   TPP+ [@b281], ethidium [@b281], N-methyl-pyridinium-2-aldoxime [@b281], N-(4′-pentanonyl)-4-(4″-dimethylamino-styryl)pyridinium [@b281]   --
  Inhibitors (pIC~50~)      reserpine (p*K*~i~ 7.45) [@b286], ketanserin (p*K*~i~ 5.8) [@b286], tetrabenazine (p*K*~i~ 4.7) [@b286]                                                                                             reserpine (p*K*~i~ 7.9) [@b286], tetrabenazine (p*K*~i~ 7.0) [@b286], ketanserin (p*K*~i~ 6.3) [@b286]                                                                                              aminobenzovesamicol (p*K*~i~ 10.9) [@b282], vesamicol (p*K*~i~ 8.7) [@b282]                                                               --
  Radioligands (*K*~d~)     --                                                                                                                                                                                                  \[11C\]DTBZ, \[125I\]8-azido-3-iodoketanserine, \[3H\]TBZOH (6.6x10^-9^ M) [@b291], \[125I\]iodovinyl-TBZ (8.2x10^-9^ M) [@b289]                                                                    \[123I\]iodobenzovesamicol, \[3H\]vesamicol (4.1x10^-9^ M) [@b291]                                                                        --
  Stoichiometry             1 amine (in): 2H^+^ (out)                                                                                                                                                                           1 amine (in): 2H^+^ (out)                                                                                                                                                                           1 amine (in): 2H^+^ (out)                                                                                                                 --
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------

Comments
========

*p*K~i~ values for endogenous and synthetic substrate inhibitors of human VMAT1 and VMAT2 are for inhibition of \[3H\]5-HT uptake in transfected and permeabilised CV-1 cells as detailed by [@b286]. In addition to the monoamines listed in the table, the trace amines tyramine and β-phenylethylamine are probable substrates for VMAT2 [@b284]. Probes listed in the table are those currently employed; additional agents have been synthesized (*e.g.* [@b292]).

SLC19 family of vitamin transporters
====================================

Overview
--------

The B vitamins folic acid and thiamine are transported across the cell membrane, particularly in the intestine, kidneys and placenta, using pH differences as driving forces. Topological modelling suggests the transporters have 12 TM domains.

  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------
  Nomenclature              Reduced folate transporter 1                                                                                                                                                      Thiamine transporter 1                                                                   Thiamine transporter 2
  Systematic nomenclature   SLC19A1                                                                                                                                                                           SLC19A2                                                                                  SLC19A3
  Common abbreviation       FOLT                                                                                                                                                                              ThTr1                                                                                    ThTr2
  HGNC, UniProt             SLC19A1, P41440                                                                                                                                                                   SLC19A2, O60779                                                                          SLC19A3, Q9BZV2
  Endogenous substrates     thiamine monophosphate [@b298], tetrahydrofolic acid [@b296], N5-methylfolate [@b296], Organic phosphates; in particular, adenine nucleotides, Other tetrahydrofolate-cofactors   thiamine                                                                                 thiamine
  Substrates                folic acid [@b296], methotrexate, folinic acid, N^5^-formyltetrahydrofolate                                                                                                       --                                                                                       --
  Radioligands (*K*~d~)     \[3H\]folic acid [@b293], \[3H\]methotrexate [@b293]                                                                                                                              \[3H\]thiamine [@b295]                                                                   \[3H\]thiamine [@b297]
  Stoichiometry             Folate (in): organic phosphate (out), precise stoichiometry unknown                                                                                                               A facilitative carrier not known to be coupled to an inorganic or organic ion gradient   A facilitative carrier not known to be coupled to an inorganic or organic ion gradient
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------

Comments
========

Loss-of-function mutations in ThTr1 underlie thiamine-responsive megaloblastic anemia syndrome [@b294].

SLC20 family of sodium-dependent phosphate transporters
=======================================================

Overview
--------

The SLC20 family is looked upon not only as ion transporters, but also as retroviral receptors. As ion transporters, they are sometimes referred to as Type III sodium-phosphate co-transporters, alongside Type I (SLC17 family) and Type II (SLC34 family). PiTs are cell-surface transporters, composed of ten TM domains with extracellular C- and N-termini. PiT1 is a focus for dietary PO34- and vitamin D regulation of parathyroid hormone secretion from the parathyroid gland. PiT2 appears to be involved in intestinal absorption of dietary PO34-.

  ------------------------- ------------------------------------------ ------------------------------------------
  Nomenclature              Sodium-dependent phosphate transporter 1   Sodium-dependent phosphate transporter 2
  Systematic nomenclature   SLC20A1                                    SLC20A2
  Common abbreviation       PiT1                                       PiT2
  HGNC, UniProt             SLC20A1, Q8WUM9                            SLC20A2, Q08357
  Substrates                AsO43− [@b299], PO34- [@b299]              PO34- [@b299]
  Stoichiometry             \>1 Na^+^: 1 HPO~4~^2-^ (in)               \>1 Na^+^: 1 HPO~4~^2-^ (in)
  ------------------------- ------------------------------------------ ------------------------------------------

SLC22 family of organic cation and anion transporters
=====================================================

Overview
--------

The SLC22 family of transporters is mostly composed of non-selective transporters, which are expressed highly in liver, kidney and intestine, playing a major role in drug disposition. The family may be divided into three subfamilies based on the nature of the substrate transported: organic cations (OCTs), organic anions (OATs) and organic zwiterrion/cations (OCTN). Membrane topology is predicted to contain 12 TM domains with intracellular termini, and an extended extracellular loop at TM 1/2.

Organic cation transporters (OCT)
---------------------------------

### Overview

Organic cation transporters (OCT) are electrogenic, Na^+^-independent and reversible.

  ------------------------- ------------------------------------------------------------- ----------------------------------------------------------------------------------------- -----------------------------------------------------------
  Nomenclature              Organic cation transporter 1                                  Organic cation transporter 2                                                              Organic cation transporter 3
  Systematic nomenclature   SLC22A1                                                       SLC22A2                                                                                   SLC22A3
  Common abbreviation       OCT1                                                          OCT2                                                                                      OCT3
  HGNC, UniProt             SLC22A1, O15245                                               SLC22A2, O15244                                                                           SLC22A3, O75751
  Endogenous substrates     5-HT, PGE2, PGF2α, choline                                    dopamine [@b303], histamine [@b303], PGE2 [@b304]                                         5-HT [@b307], (-)-noradrenaline [@b307], dopamine [@b307]
  Substrates                tetraethylammonium, desipramine, MPP+, metformin, acyclovir   (+)-tubocurarine [@b302], tetraethylammonium [@b302], pancuronium [@b302], MPP+ [@b302]   quinidine, tetraethylammonium, MPP+
  Stoichiometry             Unknown                                                       Unknown                                                                                   Unknown
  ------------------------- ------------------------------------------------------------- ----------------------------------------------------------------------------------------- -----------------------------------------------------------

#### Comments

corticosterone and quinine are able to inhibit all three organic cation transporters.

### Organic zwitterions/cation transporters (OCTN)

#### Overview

Organic zwitterions/cation transporters (OCTN) function as organic cation uniporters, organic cation/proton exchangers or sodium/L-carnitine co-transporters.

  ------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------
  Nomenclature              Organic cation/carnitine transporter 1            Organic cation/carnitine transporter 2            Carnitine transporter 2
  Systematic nomenclature   SLC22A4                                           SLC22A5                                           SLC22A16
  Common abbreviation       OCTN1                                             OCTN2                                             CT2
  HGNC, UniProt             SLC22A4, Q9H015                                   SLC22A5, O76082                                   SLC22A16, Q86VW1
  Endogenous substrates     L-carnitine                                       acetyl-L-carnitine, L-carnitine                   L-carnitine
  Substrates                pyrilamine, tetraethylammonium, verapamil, MPP+   pyrilamine, tetraethylammonium, verapamil, MPP+   --
  Stoichiometry             Unknown                                           Unknown                                           Unknown
  ------------------------- ------------------------------------------------- ------------------------------------------------- -------------------------

### Organic anion transporters (OATs)

#### Overview

Organic anion transporters (OATs) are non-selective transporters prominent in the kidney and intestine.

  ------------------------- ----------------------------------------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ----------------------------- ----------------------------- -------------------------------------------------------------------------------------------
  Nomenclature              Organic anion transporter 1                                 Organic anion transporter 2                                       Organic anion transporter 3                                                                        Organic anion transporter 7   Organic anion transporter 5   Organic anion transporter 4
  Systematic nomenclature   SLC22A6                                                     SLC22A7                                                           SLC22A8                                                                                            SLC22A9                       SLC22A10                      SLC22A11
  Common abbreviation       OAT1                                                        OAT2                                                              OAT3                                                                                               OAT4                          OAT5                          --
  HGNC, UniProt             SLC22A6, Q4U2R8                                             SLC22A7, Q9Y694                                                   SLC22A8, Q8TCC7                                                                                    SLC22A9, Q8IVM8               SLC22A10, Q63ZE4              SLC22A11, Q9NSA0
  Substrates                aminohippuric acid, non-steroidal anti-inflammatory drugs   PGE2, aminohippuric acid, non-steroidal anti-inflammatory drugs   cimetidine [@b305], ochratoxin A [@b305], estrone-3-sulphate [@b305], aminohippuric acid [@b305]   --                            ochratoxin A [@b306]          dehydroepiandrosterone sulphate [@b300], ochratoxin A [@b300], estrone-3-sulphate [@b300]
  Stoichiometry             Unknown                                                     Unknown                                                           Unknown                                                                                            Unknown                       Unknown                       Unknown
  ------------------------- ----------------------------------------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------------------------------------- ----------------------------- ----------------------------- -------------------------------------------------------------------------------------------

### Urate transporter

  ------------------------- ----------------------------------------
  Nomenclature              Urate anion exchanger 1
  Systematic nomenclature   SLC22A12
  Common abbreviation       URAT1
  HGNC, UniProt             SLC22A12, Q96S37
  Endogenous substrates     orotic acid [@b301], uric acid [@b301]
  Stoichiometry             Unknown
  ------------------------- ----------------------------------------

Orphan or poorly characterized SLC22 family members
---------------------------------------------------

  --------------------------------------- ------------------------- --------------------- ------------------
  Nomenclature                            Systematic nomenclature   Common abbreviation   HGNC, UniProt
  Organic cation transporter-like 3       SLC22A13                  ORCTL3                SLC22A13, Q9Y226
  Organic cation transporter-like 4       SLC22A14                  ORCTL4                SLC22A14, Q9Y267
  Fly-like putative transporter 1         SLC22A15                  FLIPT1                SLC22A15, Q8IZD6
  Brain-type organic cation transporter   SLC22A17                  BOIT                  SLC22A17, Q8WUG5
  Organic cation transporter-like 2       SLC22A18                  ORCTL2                SLC22A18, Q96BI1
  OAT6                                    SLC22A20                  --                    SLC22A20, A6NK97
  --                                      SLC22A23                  --                    SLC22A23, A1A5C7
  --                                      SLC22A24                  --                    SLC22A24, Q8N4F4
  UST6                                    SLC22A25                  --                    SLC22A25, Q6T423
  solute carrier family 22, member 31     SLC22A31                  --                    SLC22A31, A6NKX4
  --------------------------------------- ------------------------- --------------------- ------------------

SLC23 family of ascorbic acid transporters
==========================================

Overview
--------

Predicted to be 12 TM segment proteins, members of this family transport the reduced form of ascorbic acid (while the oxidized form may be handled by members of the SLC2 family (GLUT1/SLC2A1, GLUT3/SLC2A3 and GLUT4/SLC2A4). phloretin is considered a non-selective inhibitor of these transporters, with an affinity in the micromolar range.

  ------------------------- -------------------------------------------------------------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------
  Nomenclature              Sodium-dependent vitamin C transporter 1                             Sodium-dependent vitamin C transporter 2                             Sodium-dependent vitamin C transporter 3                                      Sodium-dependent nucleobase transporter
  Systematic nomenclature   SLC23A1                                                              SLC23A2                                                              SLC23A3                                                                       SLC23A4
  Common abbreviation       SVCT1                                                                SVCT2                                                                SVCT3                                                                         SNBT1
  HGNC, UniProt             SLC23A1, Q9UHI7                                                      SLC23A2, Q9UGH3                                                      SLC23A3, Q6PIS1                                                               SLC23A4P, --
  Endogenous substrates     L-ascorbic acid \> D-ascorbic acid \> dehydroascorbic acid [@b308]   L-ascorbic acid \> D-ascorbic acid \> dehydroascorbic acid [@b308]   --                                                                            uracil \> thymine \> guanine, hypoxanthine \> xanthine, uridine [@b309]
  Substrates                --                                                                   --                                                                   --                                                                            --
  Inhibitors (pIC~50~)      phloretin [@b308]                                                    --                                                                   --                                                                            5-fluorouracil [@b309]
  Radioligands (*K*~d~)     \[14C\]ascorbic acid                                                 \[14C\]ascorbic acid                                                 --                                                                            --
  Stoichiometry             2 Na^+^: 1 ascorbic acid (in) [@b308]                                2 Na^+^: 1 ascorbic acid (in) [@b308]                                --                                                                            1 Na^+^: 1 uracil (in) [@b309]
  Comment                   --                                                                   --                                                                   SLC23A3 does not transport ascorbic acid and remains an orphan transporter.   SLC23A4/SNBT1 is found in rodents and non-human primates, but the sequence is truncated in the human genome and named as a pseudogene, SLC23A4P
  ------------------------- -------------------------------------------------------------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------

SLC24 family of sodium/potassium/calcium exchangers
===================================================

Overview
--------

The sodium/potassium/calcium exchange family of transporters utilize the extracellular sodium gradient to drive calcium and potassium co-transport out of the cell. As is the case for NCX transporters (SLC8A family), NKCX transporters are thought to be bidirectional, with the possibility of calcium influx following depolarization of the plasma membrane. Topological modeling suggests the presence of 10 TM domains, with a large intracellular loop between the fifth and sixth TM regions.

  ------------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- --------------------------------------
  Nomenclature              Sodium/potassium/calcium exchanger 1   Sodium/potassium/calcium exchanger 2   Sodium/potassium/calcium exchanger 3   Sodium/potassium/calcium exchanger 4   Sodium/potassium/calcium exchanger 5   Sodium/potassium/calcium exchanger 6
  Systematic nomenclature   SLC24A1                                SLC24A2                                SLC24A3                                SLC24A4                                SLC24A5                                SLC24A6
  Common abbreviation       NKCX1                                  NKCX2                                  NKCX3                                  NKCX4                                  NKCX5                                  NKCX6
  HGNC, UniProt             SLC24A1, O60721                        SLC24A2, Q9UI40                        SLC24A3, Q9HC58                        SLC24A4, Q8NFF2                        SLC24A5, Q71RS6                        SLC8B1, Q6J4K2
  Stoichiometry             4Na^+^:(1Ca^2+^ + 1K^+^)               --                                     --                                     --                                     --                                     --
  ------------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- -------------------------------------- --------------------------------------

Comments
========

NKCX6 exhibits sufficient structural diversity for its function as a NKCX to be questioned [@b310].

To date, there are no agents selective for this family of transporters.

SLC25 family of mitochondrial transporters
==========================================

Overview
--------

Mitochondrial transporters are nuclear-encoded proteins, which convey solutes across the inner mitochondrial membrane. Topological modelling suggests homodimeric transporters, each with six TM segments and termini in the cytosol.

Mitochondrial di- and tri-carboxylic acid transporter subfamily
---------------------------------------------------------------

### Overview

Mitochondrial di- and tri-carboxylic acid transporters are grouped on the basis of commonality of substrates and include the citrate transporter which facilitates citric acid export from the mitochondria to allow the generation of oxalacetic acid and acetyl CoA through the action of ATP:citrate lyase.

  ------------------------- -------------------------------------- ------------------------------------------------- ----------------------------------------- ---------------------------------------- ------------------ ------------------
  Nomenclature              Mitochondrial citrate transporter      Mitochondrial dicarboxylate transporter           Mitochondrial oxoglutarate carrier        Mitochondrial oxodicarboxylate carrier   --                 --
  Systematic nomenclature   SLC25A1                                SLC25A10                                          SLC25A11                                  SLC25A21                                 SLC25A34           SLC25A35
  Common abbreviation       CIC                                    DIC                                               OGC                                       ODC                                      --                 --
  HGNC, UniProt             SLC25A1, P53007                        SLC25A10, Q9UBX3                                  SLC25A11, Q02978                          SLC25A21, Q9BQT8                         SLC25A34, Q6PIV7   SLC25A35, Q3KQZ1
  Substrates                citric acid, malic acid, PEP           malic acid, succinic acid, PO34-, S2O32-, SO42-   malic acid, α-ketoglutaric acid           α-ketoglutaric acid, α-oxoadipic acid    --                 --
  Inhibitors (pIC~50~)      1,2,3-benzenetricarboxylic acid        --                                                --                                        --                                       --                 --
  Stoichiometry             Malate^2-^ (in): H-citrate^2-^ (out)   PO~3~^4-^ (in): malate^2-^ (out)                  Malate^2-^ (in): oxoglutarate^2-^ (out)   Oxoadipate (in): oxoglutarate (out)      --                 --
  ------------------------- -------------------------------------- ------------------------------------------------- ----------------------------------------- ---------------------------------------- ------------------ ------------------

Mitochondrial amino acid transporter subfamily
----------------------------------------------

### Overview

Mitochondrial amino acid transporters can be subdivided on the basis of their substrates. Mitochondrial ornithine transporters play a role in the urea cycle by exchanging cytosolic ornithine (L-ornithine and D-ornithine) for mitochondrial citrulline (L-citrulline and D-citrulline) in equimolar amounts. Further members of the family include transporters of S-adenosylmethionine and carnitine.

  ------------------------- ----------------------------------- ----------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------
  Nomenclature              Mitochondrial glutamate carrier 1   Mitochondrial glutamate carrier 2   AGC1                                                                AGC2
  Systematic nomenclature   SLC25A22                            SLC25A18                            SLC25A12                                                            SLC25A13
  Common abbreviation       GC1                                 GC2                                 AGC1                                                                AGC2
  HGNC, UniProt             SLC25A22, Q9H936                    SLC25A18, Q9H1K4                    SLC25A12, O75746                                                    SLC25A13, Q9UJS0
  Substrates                L-glutamic acid                     L-glutamic acid                     L-glutamic acid, L-aspartic acid, 2-amino-3-sulfinopropanoic acid   L-glutamic acid, L-aspartic acid, 2-amino-3-sulfinopropanoic acid
  Stoichiometry             Glutamate: H^+^ (bidirectional)     Glutamate: H^+^ (bidirectional)     Aspartate: glutamate H^+^ (bidirectional)                           Aspartate: glutamate H^+^ (bidirectional)
  ------------------------- ----------------------------------- ----------------------------------- ------------------------------------------------------------------- -------------------------------------------------------------------

  ------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------
  Nomenclature              Mitochondrial ornithine transporter 1                                             Mitochondrial ornithine transporter 2                                                                                                                                                                        Carnitine/acylcarnitine carrier
  Systematic nomenclature   SLC25A15                                                                          SLC25A2                                                                                                                                                                                                      SLC25A20
  Common abbreviation       ORC1                                                                              ORC2                                                                                                                                                                                                         CAC
  HGNC, UniProt             SLC25A15, Q9Y619                                                                  SLC25A2, Q9BXI2                                                                                                                                                                                              SLC25A20, O43772
  Substrates                L-arginine [@b311], L-citrulline [@b311], L-lysine [@b311], L-ornithine [@b311]   L-arginine [@b311], L-citrulline [@b311], L-lysine [@b311], L-ornithine [@b311], L-histidine [@b311], D-histidine [@b311], D-arginine [@b311], D-lysine [@b311], D-ornithine [@b311], D-citrulline [@b311]   --
  Stoichiometry             1 Ornithine (in) :1 citrulline: 1 H^+^ (out)                                      1 Ornithine (in) :1 citrulline: 1 H^+^ (out)                                                                                                                                                                 --
  Comment                   --                                                                                --                                                                                                                                                                                                           Exchanges cytosolic acylcarnitine for mitochondrial carnitine
  ------------------------- --------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------

  ------------------------- ------------------------------------- ------------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Nomenclature              solute carrier family 25, member 47   solute carrier family 25, member 48   ORNT3              --                 CGI-69             MCFP               --                 --
  Systematic nomenclature   SLC25A47                              SLC25A48                              SLC25A29           SLC25A38           SLC25A39           SLC25A40           SLC25A44           SLC25A45
  Common abbreviation       --                                    --                                    ORNT3              --                 --                 --                 --                 --
  HGNC, UniProt             SLC25A47, Q6Q0C1                      SLC25A48, Q6ZT89                      SLC25A29, Q8N8R3   SLC25A38, Q96DW6   SLC25A39, Q9BZJ4   SLC25A40, Q8TBP6   SLC25A44, Q96H78   SLC25A45, Q8N413
  ------------------------- ------------------------------------- ------------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------

### Comments

Both ornithine transporters are inhibited by the polyamine spermine [@b312]. Loss-of-function mutations in these genes are associated with hyperornithinemia-hyperammonemia-homocitrullinuria.

Mitochondrial phosphate transporters
------------------------------------

### Overview

Mitochondrial phosphate transporters allow the import of inorganic PO34- for ATP production.

  ------------------------- -----------------------------------------------------
  Nomenclature              Mitochondrial phosphate carrier
  Systematic nomenclature   SLC25A3
  Common abbreviation       PHC
  HGNC, UniProt             SLC25A3, Q00325
  Stoichiometry             PO~3~^4-^ (in): OH^-^ (out) or PO~3~^4-^: H^+^ (in)
  ------------------------- -----------------------------------------------------

Mitochondrial nucleotide transporter subfamily
----------------------------------------------

### Overview

Mitochondrial nucleotide transporters, defined by structural similarlities, include the adenine nucleotide translocator family (SLC25A4, SLC25A5, SLC25A6 and SLC25A31), which under conditions of aerobic metabolism, allow coupling between mitochondrial oxidative phosphorylation and cytosolic energy consumption by exchanging cytosolic ADP for mitochondrial ATP. Further members of the mitochondrial nucleotide transporter subfamily convey diverse substrates including CoA, although not all members have had substrates identified.

  ------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------
  Nomenclature              Mitochondrial adenine nucleotide translocator 1   Mitochondrial adenine nucleotide translocator 2   Mitochondrial adenine nucleotide translocator 3   Mitochondrial adenine nucleotide translocator 4   --
  Systematic nomenclature   SLC25A4                                           SLC25A5                                           SLC25A6                                           SLC25A31                                          SLC25A42
  Common abbreviation       ANT1                                              ANT2                                              ANT3                                              ANT4                                              --
  HGNC, UniProt             SLC25A4, P12235                                   SLC25A5, P05141                                   SLC25A6, P12236                                   SLC25A31, Q9H0C2                                  SLC25A42, Q86VD7
  Inhibitors (pIC~50~)      BKA, CATR                                         --                                                --                                                --                                                --
  Stoichiometry             ADP^3-^ (in): ATP^4-^ (out)                       ADP^3-^ (in): ATP^4-^ (out)                       ADP^3-^ (in): ATP^4-^ (out)                       ADP^3-^ (in): ATP^4-^ (out)                       --
  Substrates                --                                                --                                                --                                                --                                                ADP
  ------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- ------------------

  ------------------------- ------------------------ ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------
  Nomenclature              Graves disease carrier   Peroxisomal membrane protein   Deoxynucleotide carrier 1                                                                                                                               S-Adenosylmethionine carrier
  Systematic nomenclature   SLC25A16                 SLC25A17                       SLC25A19                                                                                                                                                SLC25A26
  Common abbreviation       GDC                      PMP34                          DNC                                                                                                                                                     SAMC1
  HGNC, UniProt             SLC25A16, P16260         SLC25A17, O43808               SLC25A19, Q9HC21                                                                                                                                        SLC25A26, Q70HW3
  Substrates                CoA and congeners        ADP, ATP, AMP                  Deoxynucleotide Diphosphates (dNDPs), Deoxynucleotide Triphosphates (dNTPs), Dideoxynucleotide Triphosphates (ddNTPs), Nucleotide Diphosphates (NDPs)   S-adenosyl methionine
  Stoichiometry             CoA (in)                 ATP (in)                       dNDP (in): ATP (out)                                                                                                                                    --
  ------------------------- ------------------------ ------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------

  ------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------
  Nomenclature              Mitochondrial phosphate carrier 1   Mitochondrial phosphate carrier 2   Mitochondrial phosphate carrier 3   MFT                PNC1               --                 SCaMC-3L           --
  Systematic nomenclature   SLC25A24                            SLC25A23                            SLC25A25                            SLC25A32           SLC25A33           SLC25A36           SLC25A41           SLC25A43
  Common abbreviation       APC1                                APC2                                APC3                                MFTC               --                 PNC2               --                 --
  HGNC, UniProt             SLC25A24, Q6NUK1                    SLC25A23, Q9BV35                    SLC25A25, Q6KCM7                    SLC25A32, Q9H2D1   SLC25A33, Q9BSK2   SLC25A36, Q96CQ1   SLC25A41, Q8N5S1   SLC25A43, Q8WUT9
  ------------------------- ----------------------------------- ----------------------------------- ----------------------------------- ------------------ ------------------ ------------------ ------------------ ------------------

Mitochondrial uncoupling proteins
=================================

Overview
--------

Mitochondrial uncoupling proteins allow dissipation of the mitochondrial proton gradient associated with thermogenesis and regulation of radical formation.

  ------------------------- ---------------------- ---------------------- ----------------------
  Nomenclature              Uncoupling protein 1   Uncoupling protein 2   Uncoupling protein 3
  Systematic nomenclature   SLC25A7                SLC25A8                SLC25A9
  Common abbreviation       UCP1                   UCP2                   UCP3
  HGNC, UniProt             UCP1, P25874           UCP2, P55851           UCP3, P55916
  Stoichiometry             H^+^ (in)              H^+^ (in)              H^+^ (in)
  ------------------------- ---------------------- ---------------------- ----------------------

  ------------------------- ---------------------- ---------------------- ------------------
  Nomenclature              Uncoupling protein 4   Uncoupling protein 5   KMCP1
  Systematic nomenclature   SLC25A27               SLC25A14               SLC25A30
  Common abbreviation       UCP4                   UCP5                   --
  HGNC, UniProt             SLC25A27, O95847       SLC25A14, O95258       SLC25A30, Q5SVS4
  Stoichiometry             H^+^ (in)              H^+^ (in)              --
  ------------------------- ---------------------- ---------------------- ------------------

Miscellaneous SLC25 mitochondrial transporters
==============================================

Overview
--------

Many of the transporters identified below have yet to be assigned functions and are currently regarded as orphans.

  ------------------------- ------------------------- ------------------------- ------------------ ------------------
  Nomenclature              mitochondrial carrier 1   mitochondrial carrier 2   Mitoferrin1        Mitoferrin2
  Systematic nomenclature   SLC25A49                  SLC25A50                  SLC25A37           SLC25A28
  HGNC, UniProt             MTCH1, Q9NZJ7             MTCH2, Q9Y6C9             SLC25A37, Q9NYZ2   SLC25A28, Q96A46
  ------------------------- ------------------------- ------------------------- ------------------ ------------------

  ------------------------- ------------------------------------- ------------------------------------- ------------------------------------- ------------------
  Nomenclature              solute carrier family 25, member 51   solute carrier family 25, member 52   solute carrier family 25, member 53   --
  Systematic nomenclature   SLC25A51                              SLC25A52                              SLC25A53                              SLC25A46
  HGNC, UniProt             SLC25A51, Q9H1U9                      SLC25A52, Q3SY17                      SLC25A53, Q5H9E4                      SLC25A46, Q96AG3
  ------------------------- ------------------------------------- ------------------------------------- ------------------------------------- ------------------

SLC26 family of anion exchangers
================================

Overview
--------

Along with the SLC4 family, the SLC26 family acts to allow movement of monovalent and divalent anions across cell membranes. The predicted topology is of 10--14 TM domains with intracellular C- and N-termini, probably existing as dimers. Within the family, subgroups may be identified on the basis of functional differences, which appear to function as anion exchangers and anion channels (SLC26A7 and SLC26A9).

Selective sulphate transporters
===============================

  ------------------------- ----------------------------- ---------------------------------
  Nomenclature              Sat-1                         DTDST
  Systematic nomenclature   SLC26A1                       SLC26A2
  HGNC, UniProt             SLC26A1, Q9H2B4               SLC26A2, P50443
  Substrates                SO42-, oxalate                SO42-
  Stoichiometry             SO~4~^2-^ (in): anion (out)   1 SO~4~^2-^ (in): 2 Cl^-^ (out)
  ------------------------- ----------------------------- ---------------------------------

Chloride/bicarbonate exchangers
===============================

  ------------------------- ---------------------------------------------------------------- ---------------------------------- ------------------------------------------------------------------------
  Nomenclature              DRA                                                              Pendrin                            PAT-1
  Systematic nomenclature   SLC26A3                                                          SLC26A4                            SLC26A6
  HGNC, UniProt             SLC26A3, P40879                                                  SLC26A4, O43511                    SLC26A6, Q9BXS9
  Substrates                Cl-                                                              Cl-, HCO3-, formate, I^-^, OH^-^   Cl-, HCO3-, SO42-, oxalate, formate, I^-^, OH^-^
  Stoichiometry             2 Cl^-^ (in): 1 HCO~3~^-^ (out) or 2 Cl^-^ (in): 1 OH^-^ (out)   Unknown                            1 SO~4~^2-^ (in): 2 HCO~3~^-^ (out) or 1 Cl^-^ (in): 2 HCO~3~^-^ (out)
  ------------------------- ---------------------------------------------------------------- ---------------------------------- ------------------------------------------------------------------------

Anion channels
==============

  ---------------------------- ------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------
  Systematic nomenclature      SLC26A7                                                                  SLC26A9
  HGNC, UniProt                SLC26A7, Q8TE54                                                          SLC26A9, Q7LBE3
  Substrates                   NO3- \>\> Cl- = Br^-^ = I^-^ \> SO42- = L-glutamic acid                  I^-^ \> Br^-^ \> NO3- \> Cl- \> L-glutamic acid
  Functional characteristics   Voltage- and time-independent current, linear I-V relationship [@b315]   Voltage- and time-independent current, linear I-V relationship [@b314]
  Comment                      --                                                                       SLC26A9 has been suggested to operate in two additional modes as a Cl^-^-HCO~3~^-^ exchanger and as a Na^+^-anion cotransporter [@b313]
  ---------------------------- ------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------------------------------------------

Other SLC26 anion exchangers
============================

  ------------------------- ---------------------------------------------------------------------------------------- --------------------- ----------------------------------- ------------------
  Nomenclature              Prestin                                                                                  Tat1                  --                                  KBAT
  Systematic nomenclature   SLC26A5                                                                                  SLC26A8               SLC26A10                            SLC26A11
  Common abbreviation       --                                                                                       --                    --                                  KBAT
  HGNC, UniProt             SLC26A5, P58743                                                                          SLC26A8, Q96RN1       SLC26A10, Q8NG04                    SLC26A11, Q86WA9
  Substrates                Cl-, HCO3-                                                                               Cl-, SO42-, oxalate   --                                  HSO4-
  Stoichiometry             Unknown                                                                                  Unknown               Unknown                             Unknown
  Comment                   Prestin has been suggested to function as a molecular motor, rather than a transporter   --                    SLC26A10 is a possible pseudogene   --
  ------------------------- ---------------------------------------------------------------------------------------- --------------------- ----------------------------------- ------------------

SLC27 family of fatty acid transporters
=======================================

Overview
--------

Fatty acid transporter proteins (FATPs) are a family (SLC27) of six transporters (FATP1-6). They have at least one, and possibly six [@b319],[@b325], transmembrane segments, and are predicted on the basis of structural similarities to form dimers. SLC27 members have several structural domains: integral membrane associated domain, peripheral membrane associated domain, FATP signature, intracellular AMP binding motif, dimerization domain, lipocalin motif, and an ER localization domain (identified in FATP4 only) [@b317],[@b322],[@b323]. These transporters are unusual in that they appear to express intrinsic very long-chain acyl-CoA synthetase (EC 6.2.1.-, EC 6.2.1.7) enzyme activity. Within the cell, these transporters may associate with plasma and peroxisomal membranes. FATP1-4 and -6 transport long- and very long-chain fatty acids, while FATP5 transports long-chain fatty acids as well as bile acids [@b321],[@b325].

  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- -------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- --------------------------------------------------------------------------
  Nomenclature              Fatty acid transport protein 1                                                                                                                      Fatty acid transport protein 2   Fatty acid transport protein 3   Fatty acid transport protein 4                                                                                                                                      Fatty acid transport protein 5   Fatty acid transport protein 6
  Systematic nomenclature   SLC27A1                                                                                                                                             SLC27A2                          SLC27A3                          SLC27A4                                                                                                                                                             SLC27A5                          SLC27A6
  Common abbreviation       FATP1                                                                                                                                               FATP2                            FATP3                            FATP4                                                                                                                                                               FATP5                            FATP6
  HGNC, UniProt             SLC27A1, Q6PCB7                                                                                                                                     SLC27A2, O14975                  SLC27A3, Q5K4L6                  SLC27A4, Q6P1M0                                                                                                                                                     SLC27A5, Q9Y2P5                  SLC27A6, Q9Y2P4
  Endogenous substrates     arachidonic acid \> palmitic acid \> oleic acid \> butyric acid [@b325], palmitic acid \> oleic acid \> γ-linolenic acid \> octanoic acid [@b318]   --                               --                               palmitic acid \> oleic acid \> butyric acid, γ-linolenic acid \> arachidonic acid [@b326], palmitic acid, oleic acid \> γ-linolenic acid \> octanoic acid [@b318]   --                               palmitic acid \> oleic acid \> γ-linolenic acid \> octanoic acid [@b318]
  Comment                   --                                                                                                                                                  --                               --                               FATP4 is genetically linked to restrictive dermopathy                                                                                                               --                               --
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- -------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------- --------------------------------------------------------------------------

Comments
========

Although the stoichiometry of fatty acid transport is unclear, it has been proposed to be facilitated by the coupling of fatty acid transport to conjugation with coenzyme A to form fatty acyl CoA esters. Small molecule inhibitors of FATP2 [@b320],[@b324] and FATP4 [@b316],[@b327], as well as bile acid inhibitors of FATP5 [@b327], have been described; analysis of the mechanism of action of some of these inhibitors suggests that transport may be selectively inhibited without altering enzymatic activity of the FATP.

C1-BODIPY-C12 accumulation has been used as a non-selective index of fatty acid transporter activity.

FATP2 has two variants: Variant 1 encodes the full-length protein, while Variant 2 encodes a shorter isoform missing an internal protein segment. FATP6 also has two variants: Variant 2 encodes the same protein as Variant 1 but has an additional segment in the 5\' UTR.

SLC28 and SLC29 families of nucleoside transporters
===================================================

Overview
--------

Nucleoside transporters are divided into two families, the sodium-dependent, solute carrier family 28 (SLC28) and the equilibrative, solute carrier family 29 (SLC29), where the endogenous substrates are nucleosides.

SLC28 family
============

Overview
--------

SLC28 family members have 13 TM segments with cytoplasmic N-termini and extracellular C-termini.

  ------------------------- ----------------------------------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------
  Nomenclature              CNT1                                      CNT2                                                          CNT3
  Systematic nomenclature   SLC28A1                                   SLC28A2                                                       SLC28A3
  Common abbreviation       CNT1                                      CNT2                                                          CNT3
  HGNC, UniProt             SLC28A1, O00337                           SLC28A2, O43868                                               SLC28A3, Q9HAS3
  Endogenous substrates     adenosine, uridine, thymidine, cytidine   adenosine, inosine, guanosine, thymidine                      adenosine, inosine, uridine, guanosine, thymidine, cytidine
  Substrates                gemcitabine, zidovudine, zalcitabine      formycin B, cladribine, fludarabine, vidarabine, didanosine   5-fluorouridine, zebularine, formycin B, gemcitabine, cladribine, floxuridine, zidovudine, zalcitabine, didanosine
  Stoichiometry             1 Na^+^: 1 nucleoside (in)                1 Na^+^: 1 nucleoside (in)                                    2 Na^+^: 1 nucleoside (in)
  ------------------------- ----------------------------------------- ------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------

Comments
--------

A further two Na^+^-dependent (stoichiometry 1 Na^+^: 1 nucleoside (in)) nucleoside transporters have been defined on the basis of substrate and inhibitor selectivity: CNT4 (N4/*cit*, which transports uridine, thymidine and guanosine) and CNT5 (N5/*csg*, which transports guanosine and adenosine, and may be inhibited by NBTI).

SLC29 family
============

Overview
--------

SLC29 family members appear to be composed of 11 TM segments with cytoplasmic N-termini and extracellular C-termini. ENT1 and ENT2 are cell-surface transporters, while ENT3 is intracellular, possibly lysosomal [@b328]. ENT1-3 are described as broad-spectrum nucleoside transporters.

  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------
  Nomenclature              Equilibrative nucleoside transporter 1                                                                                                                                                                                                                                                                                                                                                                                                                                      Equilibrative nucleoside transporter 2                                                                   Equilibrative nucleoside transporter 3                                                                                                                                                  Plasma membrane monoamine transporter
  Systematic nomenclature   SLC29A1                                                                                                                                                                                                                                                                                                                                                                                                                                                                     SLC29A2                                                                                                  SLC29A3                                                                                                                                                                                 SLC29A4
  Common abbreviation       ENT1                                                                                                                                                                                                                                                                                                                                                                                                                                                                        ENT2                                                                                                     ENT3                                                                                                                                                                                    PMAT
  HGNC, UniProt             SLC29A1, Q99808                                                                                                                                                                                                                                                                                                                                                                                                                                                             SLC29A2, Q14542                                                                                          SLC29A3, Q9BZD2                                                                                                                                                                         SLC29A4, Q7RTT9
  Endogenous substrates     adenosine [@b335], inosine [@b335], hypoxanthine [@b335], uridine [@b335], guanosine [@b335], thymine [@b335], thymidine [@b335], cytidine [@b335], adenine [@b335]                                                                                                                                                                                                                                                                                                         adenosine, inosine, hypoxanthine, uridine, guanosine, thymidine                                          adenosine [@b328], inosine [@b328], uridine [@b328], guanosine [@b328], thymidine [@b328], adenine [@b328]                                                                              5-HT [@b329], dopamine [@b329], histamine [@b329], tyramine [@b329]
  Substrates                2-chloroadenosine, formycin B, tubercidin, gemcitabine, cladribine, floxuridine, pentostatin, vidarabine, cytarabine, zalcitabine, didanosine                                                                                                                                                                                                                                                                                                                               2-chloroadenosine, formycin B, tubercidin, gemcitabine, cladribine, vidarabine, zidovudine, cytarabine   cordycepin [@b328], zebularine [@b328], tubercidin [@b328], cladribine [@b328], floxuridine [@b328], fludarabine [@b328], zidovudine [@b328], zalcitabine [@b328], didanosine [@b328]   tetraethylammonium [@b329], MPP+ [@b329]
  Inhibitors (pIC~50~)      NBTI (p*K*~i~ 9.7), draflazine (p*K*~i~ 9.5), KF24345 (p*K*~i~ 9.4) [@b330], NBTGR (p*K*~i~ 9.3), dilazep (p*K*~i~ 9.0), dipyridamole (p*K*~i~ 8.5)                                                                                                                                                                                                                                                                                                                         --                                                                                                       --                                                                                                                                                                                      cimetidine [@b329], quinidine [@b329], quinine [@b329], rhodamine123 [@b329], verapamil [@b329]
  Radioligands (*K*~d~)     \[3H\]NBTI (5x10^-10^ M)                                                                                                                                                                                                                                                                                                                                                                                                                                                    --                                                                                                       --                                                                                                                                                                                      --
  Stoichiometry             Equilibrative                                                                                                                                                                                                                                                                                                                                                                                                                                                               Equilibrative                                                                                            Equilibrative                                                                                                                                                                           Equilibrative
  Comment                   ENT1 has 100-1000-fold lower affinity for nucleobases as compared with nucleosides [@b335]., The affinities of draflazine, dilazep, KF24345 and dipyridamole at ENT1 transporters are species dependent, exhibiting lower affinity at rat transporters than at human transporters [@b330],[@b333]., The loss of ENT1 activity in ENT1-null mice has been associated with a hypermineralization disorder similar to human diffuse idiopathic skeletal hyperostosis [@b334]   --                                                                                                       Defects in SLC29A3 have been implicated in Histiocytosis-lymphadenopathy plus syndrome (OMIM:602782) and lysosomal storage diseases [@b331],[@b332]                                     --
  ------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------

SLC30 zinc transporter family
=============================

Overview
--------

Along with the SLC39 family, SLC30 transporters regulate the movement of zinc ions around the cell. In particular, these transporters remove zinc ions from the cytosol, allowing accumulation into intracellular compartments or efflux through the plasma membrane. ZnT1 is thought to be placed on the plasma membrane extruding zinc, while ZnT3 is associated with synaptic vesicles and ZnT4 and ZnT5 are linked with secretory granules. Membrane topology predictions suggest a multimeric assembly, potentially heteromultimeric [@b337], with subunits having six TM domains, and both termini being cytoplasmic. Dityrosine covalent linking has been suggested as a mechanism for dimerisation, particularly for ZnT3 [@b336]. The mechanism for zinc transport is unknown.

  --------------------- ------------------------- --------------------- ------------------
  Nomenclature          Systematic nomenclature   Common abbreviation   HGNC, UniProt
  Zinc transporter 1    SLC30A1                   ZnT1                  SLC30A1, Q9Y6M5
  Zinc transporter 2    SLC30A2                   ZnT2                  SLC30A2, Q9BRI3
  Zinc transporter 3    SLC30A3                   ZnT3                  SLC30A3, Q99726
  Zinc transporter 4    SLC30A4                   ZnT4                  SLC30A4, O14863
  Zinc transporter 5    SLC30A5                   ZnT5                  SLC30A5, Q8TAD4
  Zinc transporter 6    SLC30A6                   ZnT6                  SLC30A6, Q6NXT4
  Zinc transporter 7    SLC30A7                   ZnT7                  SLC30A7, Q8NEW0
  Zinc transporter 8    SLC30A8                   ZnT8                  SLC30A8, Q8IWU4
  Zinc transporter 9    SLC30A9                   ZnT9                  SLC30A9, Q6PML9
  Zinc transporter 10   SLC30A10                  ZnT10                 SLC30A10, Q6XR72
  --------------------- ------------------------- --------------------- ------------------

Comments
========

ZnT8/SLC30A8 is described as a type 1 diabetes susceptibility gene.

Zinc fluxes may be monitored through the use of radioisotopic Zn-65 or the fluorescent dye FluoZin 3.

SLC31 family of copper transporters
===================================

Overview
--------

SLC31 family members, alongside the Cu-ATPases are involved in the regulation of cellular copper levels. The CTR1 transporter is a cell-surface transporter to allow monovalent copper accumulation into cells, while CTR2 appears to be a vacuolar/vesicular transporter [@b341]. Functional copper transporters appear to be trimeric with each subunit having three TM regions and an extracellular N-terminus. CTR1 is considered to be a higher affinity copper transporter compared to CTR2. The stoichiometry of copper accumulation is unclear, but appears to be energy-independent [@b340].

  ------------------------- ---------------------- ----------------------
  Nomenclature              Copper transporter 1   Copper transporter 2
  Systematic nomenclature   SLC31A1                SLC31A2
  Common abbreviation       CTR1                   CTR2
  HGNC, UniProt             SLC31A1, O15431        SLC31A2, O15432
  Endogenous substrates     copper [@b340]         copper
  Substrates                cisplatin [@b339]      cisplatin [@b338]
  Stoichiometry             Unknown                Unknown
  ------------------------- ---------------------- ----------------------

Comments
========

Copper accumulation through CTR1 is sensitive to silver ions, but not divalent cations [@b340].

SLC32 vesicular inhibitory amino acid transporter
=================================================

Overview
--------

The vesicular inhibitory amino acid transporter, VIAAT (also termed the vesicular GABA transporter VGAT), which is the sole representative of the SLC32 family, transports GABA, or glycine, into synaptic vesicles [@b343],[@b344], and is a member of the structurally-defined amino acid-polyamine-organocation/APC clan composed of SLC32, SLC36 and SLC38 transporter families (see [@b349]). VIAAT was originally suggested to be composed of 10 TM segments with cytoplasmic N- and C-termini [@b347]. However, an alternative 9TM structure with the N terminus facing the cytoplasm and the C terminus residing in the synaptic vesicle lumen has subsequently been reported [@b346]. VIAAT acts as an antiporter for inhibitory amino acids and protons. The accumulation of GABA and glycine within vesicles is driven by both the chemical (ΔpH) and electrical (Δψ) components of the proton electrochemical gradient (Δμ~H~+) established by a vacuolar H^+^-ATPase [@b347]. However, one study, [@b345], presented evidence that VIAAT is instead a Cl^-^/GABA co-transporter. VIAAT co-exists with VGLUT1 (SLC17A7), or VGLUT2 (SLC17A6), in the synaptic vesicles of selected nerve terminals [@b342],[@b351]. VIAAT knock out mice die between embryonic day 18.5 and birth [@b350]. In cultures of spinal cord neurones established from earlier embryos, the co-release of of GABA and glycine from synaptic vesicles is drastically reduced, providing direct evidence for the role of VIAAT in the sequestration of both transmitters [@b348],[@b350].

  ------------------------- ------------------------------------------------------------------------------
  Nomenclature              Vesicular inhibitory amino acid transporter
  Systematic nomenclature   SLC32A1
  Common abbreviation       VIAAT
  HGNC, UniProt             SLC32A1, Q9H598
  Endogenous substrates     glycine, β-alanine, γ-hydroxybutyric acid, GABA (Km 5x10^-3^ M) [@b347]
  Inhibitors (pIC~50~)      vigabatrin (2.1) [@b347]
  Stoichiometry             1 amino acid (in): 1 H^+^ (out) [@b344] or 1 amino acid: 2Cl^-^ (in) [@b345]
  ------------------------- ------------------------------------------------------------------------------

SLC33 acetylCoA transporter
===========================

Overview
--------

Acetylation of proteins is a post-translational modification mediated by specific acetyltransferases, using the donor acetyl CoA. SLC33A1/AT1 is a putative 11 TM transporter present on the endoplasmic reticulum, expressed in all tissues, but particularly abundant in the pancreas [@b353], which imports cytosolic acetyl CoA into these intracellular organelles.

  ------------------------- -----------------------
  Nomenclature              AcetylCoA transporter
  Systematic nomenclature   SLC33A1
  Common abbreviation       ACATN1
  HGNC, UniProt             SLC33A1, O00400
  Endogenous substrates     acetyl CoA
  Radioligands (*K*~d~)     \[14C\]acetylCoA
  Stoichiometry             Unknown
  ------------------------- -----------------------

Comments
========

In heterologous expression studies, acetyl CoA transport through AT1 was inhibited by coenzyme A, but not acetic acid, ATP or UDP-galactose [@b352]. A loss-of-function mutation in ACATN1/SLC33A1 has been associated with spastic paraplegia (SPG42, [@b354]), although this observation could not be replicated in a subsequent study [@b355].

SLC34 family of sodium phosphate co-transporters
================================================

Overview
--------

The SLC34 family are sometimes referred to as Type II sodium-phosphate co-transporters, alongside Type I (SLC17 family) and Type III (SLC20 family) transporters. Topological modelling suggests eight TM domains with C- and N- termini in the cytoplasm, and a re-entrant loop at TM7/8. SLC34 family members are expressed on the apical surfaces of epithelia in the intestine and kidneys to regulate body phosphate levels, principally NaPi-IIa and NaPi-IIb, respectively. NaPi-IIa and NaPi-IIb are electrogenic, while NaPiIIc is electroneutral [@b356].

  ------------------------- ------------------------------------ ------------------------------------ ------------------------------------
  Nomenclature              Sodium phosphate 1                   Sodium phosphate 2                   Sodium phosphate 3
  Systematic nomenclature   SLC34A1                              SLC34A2                              SLC34A3
  Common abbreviation       NaPi-IIa                             NaPi-IIb                             NaPi-IIc
  HGNC, UniProt             SLC34A1, Q06495                      SLC34A2, O95436                      SLC34A3, Q8N130
  Stoichiometry             3 Na^+^: 1 HPO~4~^2-^ (in) [@b357]   3 Na^+^: 1 HPO~4~^2-^ (in) [@b356]   2 Na^+^: 1 HPO~4~^2-^ (in) [@b356]
  ------------------------- ------------------------------------ ------------------------------------ ------------------------------------

Comments
========

These transporters can be inhibited by PFA, in contrast to type III sodium-phosphate cotransporters, the SLC20 family.

SLC35 family of nucleotide sugar transporters
=============================================

Overview
--------

Glycoprotein formation in the Golgi and endoplasmic reticulum relies on the accumulation of nucleotide-conjugated sugars via the SLC35 family of transporters. These transporters have a predicted topology of 10 TM domains, with cytoplasmic termini, and function as exchangers, swopping nucleoside monophosphates for the corresponding nucleoside diphosphate conjugated sugar. Five subfamilies of transporters have been identified on the basis of sequence similarity, namely SLC35A1, SLC35A2, SLC35A3, SLC35A4 and SLC35A5; SLC35B1, SLC35B2, SLC35B3 and SLC35B4; SLC35C1 and SLC35C2; SLC35D1, SL35D1, SLC35D2 and SLC35D3, and the subfamily of orphan SLC35 transporters, SLC35E1-4 and SLC35F1-5.

  ------------------------- ----------------------------- ------------------------------------------------------------------------- ------------------------------------- ----------------- -----------------
  Nomenclature              CMP-sialic acid transporter   UDP-galactose transporter                                                 UDP-N-acetylglucosamine transporter   MGC2541           FLJ11130
  Systematic nomenclature   SLC35A1                       SLC35A2                                                                   SLC35A3                               SLC35A4           SLC35A5
  HGNC, UniProt             SLC35A1, P78382               SLC35A2, P78381                                                           SLC35A3, Q9Y2D2                       SLC35A4, Q96G79   SLC35A5, Q9BS91
  Substrates                CMP-sialic acid [@b359]       UDP N-acetyl-glucosamine [@b361],[@b366], UDP-galactose [@b361],[@b366]   UDP N-acetyl-glucosamine [@b362]      --                --
  ------------------------- ----------------------------- ------------------------------------------------------------------------- ------------------------------------- ----------------- -----------------

  ------------------------- ----------------- -------------------- -------------------- ------------------------------------------------------
  Nomenclature              UGTREL1           PAPS transporter 1   PAPS transporter 2   YEA
  Systematic nomenclature   SLC35B1           SLC35B2              SLC35B3              SLC35B4
  HGNC, UniProt             SLC35B1, P78383   SLC35B2, Q8TB61      SLC35B3, Q9H1N7      SLC35B4, Q969S0
  Substrates                --                A3P5PS [@b364]       A3P5PS [@b363]       UDP N-acetyl-glucosamine [@b358], UDP-xylose [@b358]
  ------------------------- ----------------- -------------------- -------------------- ------------------------------------------------------

  ------------------------- ------------------------ ----------------- ---------------------------------------------------------------- ----------------------------------- -----------------
  Nomenclature              GDP-Fucose transporter   OVCOV1            UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter   HFRC1                               FRCL1
  Systematic nomenclature   SLC35C1                  SLC35C2           SLC35D1                                                          SLC35D2                             SLC35D3
  HGNC, UniProt             SLC35C1, Q96A29          SLC35C2, Q9NQQ7   SLC35D1, Q9NTN3                                                  SLC35D2, Q76EJ3                     SLC35D3, Q5M8T2
  Substrates                GDP-fucose [@b365]       --                UDP-glucuronic acid [@b367], UDP-N-acetylgalactosamine [@b367]   UDP-N-acetylgalactosamine [@b360]   --
  ------------------------- ------------------------ ----------------- ---------------------------------------------------------------- ----------------------------------- -----------------

  ------------------------- -------------------- -------------------- -------------------------------------- -------------------- --------------------
  Nomenclature              --                   --                   solute carrier family 35, member E2B   --                   --
  Systematic nomenclature   SLC35E1              SLC35E2              SLC35E2B                               SLC35E3              SLC35E4
  HGNC, UniProt             SLC35E1, Q96K37      SLC35E2, P0CK97      SLC35E2B, P0CK96                       SLC35E3, Q7Z769      SLC35E4, Q6ICL7
  Comment                   Orphan transporter   Orphan transporter   --                                     Orphan transporter   Orphan transporter
  ------------------------- -------------------- -------------------- -------------------------------------- -------------------- --------------------

  ------------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------------------------
  Nomenclature              --                   --                   --                   --                   --                   solute carrier family 35, member F6
  Systematic nomenclature   SLC35F1              SLC35F2              SLC35F3              SLC35F4              SLC35F5              SLC35F6
  HGNC, UniProt             SLC35F1, Q5T1Q4      SLC35F2, Q8IXU6      SLC35F3, Q8IY50      SLC35F4, A4IF30      SLC35F5, Q8WV83      SLC35F6, Q8N357
  Comment                   Orphan transporter   Orphan transporter   Orphan transporter   Orphan transporter   Orphan transporter   --
  ------------------------- -------------------- -------------------- -------------------- -------------------- -------------------- -------------------------------------

  ------------------------- ------------------------------------- ------------------------------------- ------------------------------------- ------------------------------------- -------------------------------------
  Nomenclature              solute carrier family 35, member G1   solute carrier family 35, member G3   solute carrier family 35, member G4   solute carrier family 35, member G5   solute carrier family 35, member G6
  Systematic nomenclature   SLC35G1                               SLC35G3                               SLC35G4                               SLC35G5                               SLC35G6
  HGNC, UniProt             SLC35G1, Q2M3R5                       SLC35G3, Q8N808                       SLC35G4, P0C7Q5                       SLC35G5, Q96KT7                       SLC35G6, P0C7Q6
  ------------------------- ------------------------------------- ------------------------------------- ------------------------------------- ------------------------------------- -------------------------------------

SLC36 family of proton-coupled amino acid transporters
======================================================

Overview
--------

The SLC36 family of proton-coupled amino acid transporters (or PAT) is highly expressed in the intestine and kidney, having roles in the disposition of amino acids [@b383]. PAT1 is found on the gut epithelia luminal surface accumulating dietary amino acids, and additionally in lysosomal membranes where it likely functions as an efflux mechanism for amino acids produced during intralysosomal proteolysis [@b369],[@b382]. PAT2 is found at the apical membrane of the kidney proximal tubule [@b372]. PAT1 and PAT2 are predicted to have 11 TM domains with intracellular N-termini [@b370],[@b382].

  ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ----------------------------------------- -----------------------------------------
  Nomenclature              Proton-coupled Amino acid Transporter 1                                                                                                                       Proton-coupled Amino acid Transporter 2                                        Proton-coupled Amino acid Transporter 3   Proton-coupled Amino acid Transporter 4
  Systematic nomenclature   SLC36A1                                                                                                                                                       SLC36A2                                                                        SLC36A3                                   SLC36A4
  Common abbreviation       PAT1                                                                                                                                                          PAT2                                                                           PAT3                                      PAT4
  HGNC, UniProt             SLC36A1, Q7Z2H8                                                                                                                                               SLC36A2, Q495M3                                                                SLC36A3, Q495N2                           SLC36A4, Q6YBV0
  Endogenous substrates     L-alanine, glycine, GABA, β-alanine, taurine, L-proline, D-serine, D-cysteine, D-proline, D-alanine, trans-4-hydroxy-proline, sarcosine                       L-alanine, glycine, β-alanine, L-proline, trans-4-hydroxy-proline, sarcosine   --                                        L-tryptophan [@b381], L-proline [@b381]
  Substrates                THIP [@b378], betaine, L-azetidine-2-carboxylate [@b377], MeAIB [@b373], β-guanidinopropionic acid, THPO [@b379], 5-aminolevulinic acid, vigabatrin [@b368]   L-azetidine-2-carboxylate [@b377], MeAIB [@b374]                               --                                        --
  Inhibitors (pIC~50~)      5-hydroxy-L-tryptophan (p*K*~i~ 3.0) [@b380], indole-3-propionic acid (p*K*~i~ 2.3) [@b380], L-tryptophan (p*K*~i~ 2.3) [@b380], 5-HT (p*K*~i~ 2.2) [@b380]   5-hydroxy-L-tryptophan (2.8) [@b375], α-methyl-D,L-tryptophan (2.5) [@b375]    --                                        --
  Stoichiometry             1 H^+^: 1 amino acid (in)                                                                                                                                     1 H^+^: 1 amino acid (in)                                                      Unknown                                   Unknown
  Comment                   \[^3^H\] or \[^14^C\] labelled substrates as listed above are used as probes                                                                                  \[^3^H\] or \[^14^C\] labelled substrates as listed above are used as probes   --                                        --
  ------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ----------------------------------------- -----------------------------------------

Comments
========

Both PAT1 and PAT2 can also function as an electroneutral transport system for H^+^ and fatty acids including acetic acid, propanoic acid and butyric acid [@b376].

Loss-of-function mutations in PAT2 lead to iminoglycinuria and hyperglycinuria in man [@b371].

SLC37 family of phosphosugar/phosphate exchangers
=================================================

Overview
--------

The family of sugar-phosphate exchangers pass particular phosphorylated sugars across intracellular membranes, exchanging for inorganic phosphate. Of the family of sugar phosphate transporters, most information is available on SPX4, the glucose-6-phosphate transporter. This is a 10 TM domain protein with cytoplasmic termini and is associated with the endoplasmic reticulum, with tissue-specific splice variation.

  ------------------------- --------------------------------------------------- --------------------------------------------------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------
  Nomenclature              Glycerol-3-phosphate transporter                    SPX2                                                SPX3              Glucose-6-phosphate transporter
  Systematic nomenclature   SLC37A1                                             SLC37A2                                             SLC37A3           SLC37A4
  Common abbreviation       SPX1                                                --                                                  --                SPX4
  HGNC, UniProt             SLC37A1, P57057                                     SLC37A2, Q8TED4                                     SLC37A3, Q8NCC5   SLC37A4, O43826
  Endogenous substrates     glucose 6-phosphate, glycerol 3-phosphate           glucose 6-phosphate                                 --                glucose 6-phosphate
  Stoichiometry             Glucose 6-phosphate (in): phosphate (out) [@b386]   Glucose 6-phosphate (in): phosphate (out) [@b386]   Unknown           Glucose 6-phosphate (in): phosphate (out) [@b385]
  Comment                   --                                                  --                                                  --                Multiple polymorphisms have been described for the SLC37A4 gene, some of which associate with a glycogen storage disease [@b384]
  ------------------------- --------------------------------------------------- --------------------------------------------------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------

SLC38 family of sodium-dependent neutral amino acid transporters
================================================================

Overview
--------

The SLC38 family of transporters appears to be responsible for the functionally-defined system A and system N mechanisms of amino acid transport and are mostly expressed in the CNS. Two distinct subfamilies are identifiable within the SLC38 transporters. SNAT1, SNAT2 and SNAT4 appear to resemble system A transporters in accumulating neutral amino acids under the influence of the sodium gradient. SNAT3 and SNAT5 appear to resemble system N transporters in utilizing proton co-transport to accumulate amino acids. The predicted membrane topology is of 11 TM domains with an extracellular C-terminus and intracellular N-terminus [@b394].

System A-like transporters
==========================

  ------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------
  Nomenclature              SNAT1                                                                                                                                                      SNAT2                                                                                                                                   SNAT4
  Systematic nomenclature   SLC38A1                                                                                                                                                    SLC38A2                                                                                                                                 SLC38A4
  Common abbreviation       SNAT1                                                                                                                                                      SNAT2                                                                                                                                   SNAT4
  HGNC, UniProt             SLC38A1, Q9H2H9                                                                                                                                            SLC38A2, Q96QD8                                                                                                                         SLC38A4, Q969I6
  Endogenous substrates     L-alanine \> L-serine, L-glutamine, L-asparagine, L-histidine, L-cysteine, L-methionine \> glycine, L-threonine, L-proline, L-tyrosine, L-valine [@b387]   L-alanine, L-methionine \> L-asparagine, L-glutamine, L-serine, L-proline, glycine \> L-threonine, L-leucine, L-phenylalanine [@b391]   L-histidine \> L-arginine, L-alanine, L-asparagine, L-lysine \> glycine, L-glutamine, L-serine, L-proline, L-leucine, L-phenylalanine [@b390]
  Substrates                MeAIB                                                                                                                                                      MeAIB                                                                                                                                   MeAIB
  Radioligands (*K*~d~)     \[14C\]alanine, \[3H\]alanine                                                                                                                              \[14C\]alanine, \[3H\]alanine                                                                                                           \[14C\]alanine, \[14C\]glycine, \[3H\]alanine, \[3H\]glycine
  Stoichiometry             1 Na^+^: 1 amino acid (in) [@b387]                                                                                                                         1 Na^+^: 1 amino acid (in) [@b391]                                                                                                      1 Na^+^: 1 neutral amino acid (in) [@b390]
  Comment                   --                                                                                                                                                         --                                                                                                                                      Transport of cationic amino acids by SNAT4 was sodium-independent [@b390]
  ------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------

System N-like transporters
==========================

  ------------------------- -------------------------------------------------------------------------------- --------------------------------------------------------------------------------
  Nomenclature              SNAT3                                                                            SNAT5
  Systematic nomenclature   SLC38A3                                                                          SLC38A5
  Common abbreviation       SNAT3                                                                            SNAT5
  HGNC, UniProt             SLC38A3, Q99624                                                                  SLC38A5, Q8WUX1
  Endogenous substrates     L-histidine, L-glutamine \> L-asparagine, L-alanine \> L-glutamic acid [@b389]   L-asparagine, L-serine, L-histidine, L-glutamine \> glycine, L-alanine [@b393]
  Substrates                MeAIB                                                                            MeAIB
  Radioligands (*K*~d~)     \[14C\]glutamine, \[3H\]glutamine                                                \[14C\]histidine, \[3H\]histidine
  Stoichiometry             1 Na^+^: 1 amino acid (in): 1 H^+^ (out) [@b388]                                 1 Na^+^: 1 amino acid (in): 1 H^+^ (out) [@b393]
  ------------------------- -------------------------------------------------------------------------------- --------------------------------------------------------------------------------

Orphan SLC38 transporters
=========================

  ------------------------- ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------- ----------------- ------------------ ------------------
  Nomenclature              SNAT6             SNAT7                                                                                                                                                        --                --                PP1744             AVT2
  Systematic nomenclature   SLC38A6           SLC38A7                                                                                                                                                      SLC38A8           SLC38A9           SLC38A10           SLC38A11
  Common abbreviation       SNAT6             SNAT7                                                                                                                                                        --                --                --                 --
  HGNC, UniProt             SLC38A6, Q8IZM9   SLC38A7, Q9NVC3                                                                                                                                              SLC38A8, A6NNN8   SLC38A9, Q8NBW4   SLC38A10, Q9HBR0   SLC38A11, Q08AI6
  Comment                   --                SNAT7/SLC38A7 has been described to be a system N-like transporter allowing preferential accumulation of L-glutamine, L-histidine and L-asparagine [@b392]   --                --                --                 --
  ------------------------- ----------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------- ----------------- ------------------ ------------------

SLC39 family of metal ion transporters
======================================

Overview
--------

Along with the SLC30 family, SLC39 family members regulate zinc movement in cells. SLC39 metal ion transporters accumulate zinc into the cytosol. Membrane topology modelling suggests the presence of eight TM regions with both termini extracellular or in the lumen of intracellular organelles. The mechanism for zinc transport for many members is unknown but appears to involve co-transport of bicarbonate ions [@b396],[@b397].

  ------------------------- -------------------- -------------------- -------------------- -------------------- ------------------------- -------------------- --------------------
  Nomenclature              Zinc transporter 1   Zinc transporter 2   Zinc transporter 3   Zinc transporter 4   metal ion transporter 5   Zinc transporter 6   Zinc transporter 7
  Systematic nomenclature   SLC39A1              SLC39A2              SLC39A3              SLC39A4              SLC39A5                   SLC39A6              SLC39A7
  Common abbreviation       ZIP1                 ZIP2                 ZIP3                 ZIP4                 ZIP5                      ZIP6                 ZIP7
  HGNC, UniProt             SLC39A1, Q9NY26      SLC39A2, Q9NP94      SLC39A3, Q9BRY0      SLC39A4, Q6P5W5      SLC39A5, Q6ZMH5           SLC39A6, Q13433      SLC39A7, Q92504
  ------------------------- -------------------- -------------------- -------------------- -------------------- ------------------------- -------------------- --------------------

  ------------------------- ----------------------------------------- -------------------- --------------------- --------------------- --------------------- --------------------- ----------------------------------------------
  Nomenclature              Zinc transporter 8                        Zinc transporter 9   Zinc transporter 10   Zinc transporter 11   Zinc transporter 12   Zinc transporter 13   Zinc transporter 14
  Systematic nomenclature   SLC39A8                                   SLC39A9              SLC39A10              SLC39A11              SLC39A12              SLC39A13              SLC39A14
  Common abbreviation       ZIP8                                      ZIP9                 ZIP10                 ZIP11                 ZIP12                 ZIP13                 ZIP14
  HGNC, UniProt             SLC39A8, Q9C0K1                           SLC39A9, Q9NUM3      SLC39A10, Q9ULF5      SLC39A11, Q8N1S5      SLC39A12, Q504Y0      SLC39A13, Q96H72      SLC39A14, Q15043
  Substrates                Cd2+ [@b395],[@b397]                      --                   --                    --                    --                    --                    Cd2+ [@b396], Fe^2+^ [@b398], Mn^2+^ [@b396]
  Stoichiometry             1 Zn^2+^ (in): 2 HCO~3~^-^ (in) [@b397]   --                   --                    --                    --                    --                    --
  ------------------------- ----------------------------------------- -------------------- --------------------- --------------------- --------------------- --------------------- ----------------------------------------------

Comments
========

Zinc fluxes may be monitored through the use of radioisotopic Zn-65 or the fluorescent dye FluoZin 3.

The bicarbonate transport inhibitor DIDS has been reported to inhibit cation accumulation through ZIP14 [@b396].

SLC40 iron transporter
======================

Overview
--------

Alongside the SLC11 family of proton-coupled metal transporters, ferroportin allows the accumulation of iron from the diet. Whilst SLC11A2 functions on the apical membrane, ferroportin acts on the basolateral side of the enterocyte, as well as regulating macrophage and placental iron levels. The predicted topology is of 12 TM domains, with intracellular termini [@b403], with the functional transporter potentially a dimeric arrangement [@b399],[@b400].

  ------------------------- -----------------
  Nomenclature              Ferroportin
  Systematic nomenclature   SLC40A1
  Common abbreviation       IREG1
  HGNC, UniProt             SLC40A1, Q9NP59
  Endogenous substrates     Fe^2+^
  Stoichiometry             Unknown
  ------------------------- -----------------

Comments
========

Hepcidin (HAMP, P81172), cleaved into hepcidin-25 (HAMP, P81172) and hepcidin-20 (HAMP, P81173), is a small protein that increases upon inflammation, binds to ferroportin to regulate its cellular distribution and degradation. Gene disruption in mice results in embryonic lethality [@b402], while loss-of-function mutations in man are associated with haemochromatosis [@b401].

SLC41 family of divalent cation transporters
============================================

Overview
--------

By analogy with bacterial orthologues, this family is probably magnesium transporters. The prokaryote orthologue, MgtE, is responsible for uptake of divalent cations, while the heterologous expression studies of mammalian proteins suggest Mg^2+^ efflux [@b406], possibly as a result of co-expression of particular protein partners (see [@b407]). Topological modelling suggests 10 TM domains with cytoplasmic C- and N- termini.

  ------------------------- ---------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ -----------------
  Systematic nomenclature   SLC41A1                                                                                                                SLC41A2                                                                                    SLC41A3
  Common abbreviation       MgtE                                                                                                                   --                                                                                         --
  HGNC, UniProt             SLC41A1, Q8IVJ1                                                                                                        SLC41A2, Q96JW4                                                                            SLC41A3, Q96GZ6
  Substrates                Zn2+ [@b404], Mg2+ [@b404], Ba2+ [@b404], Cd2+ [@b404], Co^2+^ [@b404], Cu2+ [@b404], Fe^2+^ [@b404], Sr^2+^ [@b404]   Mg2+ [@b405], Ba2+ [@b405], Ni2+ [@b405], Co^2+^ [@b405], Fe^2+^ [@b405], Mn^2+^ [@b405]   --
  Stoichiometry             Unknown                                                                                                                Unknown                                                                                    Unknown
  ------------------------- ---------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------ -----------------

SLC42 family of Rhesus glycoprotein ammonium transporters
=========================================================

Overview
--------

LAT3 (SLC43A1) and LAT4 (SLC43A2) are transporters with system L amino acid transporter activity, along with the structurally and functionally distinct transporters LAT1 and LAT2 that are members of the SLC7 family. LAT3 and LAT4 contain 12 putative TM domains with both N and C termini located intracellularly. They transport neutral amino acids in a manner independent of Na^+^ and Cl^-^ and with two kinetic components [@b412],[@b413]. LAT3/SLC43A1 is expressed in human tissues at high levels in the pancreas, liver, skeletal muscle and fetal liver [@b412] whereas LAT4/SLC43A2 is primarily expressed in the placenta, kidney and peripheral blood leukocytes [@b413]. SLC43A3 is expressed in vascular endothelial cells [@b414] but remains to be characterised.

  ------------------------- ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- -----------------
  Nomenclature              L-type amino acid transporter 3                                                                             L-type amino acid transporter 4                                                           EEG1
  Systematic nomenclature   SLC43A1                                                                                                     SLC43A2                                                                                   SLC43A3
  Common abbreviation       LAT3                                                                                                        LAT4                                                                                      --
  HGNC, UniProt             SLC43A1, O75387                                                                                             SLC43A2, Q8N370                                                                           SLC43A3, Q8NBI5
  Substrates                L-isoleucine, L-leucine, L-phenylalanine, L-valinol, L-leucinol, L-phenylalaninol, L-valine, L-methionine   L-isoleucine, L-leucine, L-phenylalanine, L-valinol, L-leucinol, L-valine, L-methionine   --
  Stoichiometry             Operates by facilitative diffusion                                                                          Operates by facilitative diffusion                                                        --
  ------------------------- ----------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- -----------------

Comments
========

Covalent modification of LAT3 by N-ethylmaleimide inhibits its function [@b412] and at LAT4 inhibits the low-, but not high-affinity component of transport [@b413].

SLC44 choline transporter-like family
=====================================

Overview
--------

Members of the choline transporter-like family are encoded by five genes (CTL1-CTL5) with further diversity occurring through alternative splicing of CTL1, 4 and 5 [@b423]. CTL family members are putative 10TM domain proteins with extracellular termini that mediate Na^+^-independent transport of choline with an affinity that is intermediate to that of the high affinity choline transporter CHT1 (SLC5A7) and the low affinity organic-cation transporters \[OCT1 (SLC22A1) and OCT2 (SLC22A2)\] [@b420]. CLT1 is expressed almost ubiquitously in human tissues [@b425] and mediates choline transport across the plasma and mitochondrial membranes [@b419]. Transport of choline by CTL2, which in rodents is expressed as two isoforms (CTL2P1 and CLTP2; [@b417]) in lung, colon, inner ear and spleen and to a lesser extent in brain, tongue, liver, and kidney, has only recently been demonstrated [@b417],[@b422]. CTL3-5 remain to be characterized functionally.

  ------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ---------------------------- ---------------------------- ----------------------------
  Nomenclature              Choline transporter-like 1                                                                                                                                                                      Choline transporter-like 2   Choline transporter-like 3   Choline transporter-like 4   Choline transporter-like 5
  Systematic nomenclature   SLC44A1                                                                                                                                                                                         SLC44A2                      SLC44A3                      SLC44A4                      SLC44A5
  Common abbreviation       CTL1                                                                                                                                                                                            CTL2                         CTL3                         CTL4                         CTL5
  HGNC, UniProt             SLC44A1, Q8WWI5                                                                                                                                                                                 SLC44A2, Q8IWA5              SLC44A3, Q8N4M1              SLC44A4, Q53GD3              SLC44A5, Q8NCS7
  Substrates                choline                                                                                                                                                                                         choline                      --                           --                           --
  Inhibitors (pIC~50~)      hemicholinium-3 (p*K*~i~ 3.5 -- 4.5)                                                                                                                                                            --                           --                           --                           --
  Stoichiometry             Unknown: uptake enhanced in the absence of extracellular Na^+^, reduced by membrane depolarization, extracellular acidification and collapse of plasma membrane H^+^ electrochemical gradient   --                           --                           --                           --
  ------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------- ---------------------------- ---------------------------- ----------------------------

Comments
========

Data tabulated are features observed for CLT1 endogenous to: rat astrocytes [@b416]; rat renal tubule epithelial cells [@b426]; human colon carcinoma cells [@b418]; human keratinocytes [@b424] and human neuroblastoma cells [@b427]. Choline uptake by CLT1 is inhibited by numerous organic cations (*e.g.* [@b416],[@b426],[@b427]). In the guinea-pig, CTL2 is a target for antibody-induced hearing loss [@b421] and in man, a polymorphism in CTL2 constitutes the human neutrophil alloantigen-3a (HNA-3a; [@b415]).

SLC45 family of putative sugar transporters
===========================================

Overview
--------

Members of the SLC45 family remain to be fully characterised. SLC45A1 was initially identified in the rat brain, particularly predominant in the hindbrain, as a proton-associated sugar transport, induced by hypercapnia [@b430]. The protein is predicted to have 12TM domains, with intracellular termini. The *SLC45A2* gene is thought to encode a transporter protein that mediates melanin synthesis. Mutations in *SLC45A2* are a cause of oculocutaneous albinism type 4 (*e.g.* [@b429]), and polymorphisms in this gene are associated with variations in skin and hair color (*e.g*. [@b428]).

  ------------------------- -------------------------------------------------- ----------------- ----------------- -----------------
  Systematic nomenclature   SLC45A1                                            SLC45A2           SLC45A3           SLC45A4
  HGNC, UniProt             SLC45A1, Q9Y2W3                                    SLC45A2, Q9UMX9   SLC45A3, Q96JT2   SLC45A4, Q5BKX6
  Substrates                L-glucose (Rat) [@b430], Galactose (Rat) [@b430]   --                --                --
  Stoichiometry             Unknown; increased at acid pH [@b430].             --                --                --
  ------------------------- -------------------------------------------------- ----------------- ----------------- -----------------

SLC46 family of folate transporters
===================================

Overview
--------

Based on the proptypical member of this family, PCFT, this family includes proton-driven transporters with 11 TM segments. SLC46A1 has been described to act as an intestinal proton-coupled high-affinity folic acid transporter [@b432], with lower affinity for heme. folic acid accumulation is independent of Na^+^ or K^+^ ion concentrations, but driven by extracellular protons with an as yet undefined stoichiometry.

  ------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------- -------------------------
  Nomenclature              Proton-coupled folate transporter                                                                                  Thymic stromal co-transporter   --
  Systematic nomenclature   SLC46A1                                                                                                            SLC46A2                         SLC46A3
  Common abbreviation       PCFT                                                                                                               TSCOT                           --
  HGNC, UniProt             SLC46A1, Q96NT5                                                                                                    SLC46A2, Q9BY10                 SLC46A3, Q7Z3Q1
  Substrates                folic acid (1.3μM) \> heme (\>100 μM) [@b431]                                                                      --                              --
  Endogenous substrates     N^5^-methyltetrafolate [@b432]                                                                                     --                              --
  Substrates                methotrexate [@b432], N-formyltetrahydrofolate, pemetrexed                                                         --                              --
  Radioligands (*K*~d~)     \[3H\]folic acid, \[3H\]folinic acid, \[3H\]methotrexate, \[3H\]N5-methylfolate, \[3H\]pemetrexed                  --                              --
  Comment                   Loss-of-function mutations in PCFT (SLC46A1) are the molecular basis for hereditary folate maladsorption [@b433]   Function as-yet unknown         Function as-yet unknown
  ------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------- -------------------------

SLC47 family of multidrug and toxin extrusion transporters
==========================================================

Overview
--------

These proton:organic cation exchangers are predicted to have 13 TM segments [@b443] and are suggested to be responsible for excretion of many drugs in the liver and kidneys.

  -------------------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------
  Nomenclature                                 Multi antimicrobial extrusion protein                                                             MATE2
  Systematic nomenclature                      SLC47A1                                                                                           SLC47A2
  Common abbreviation                          MATE1                                                                                             MATE2-K
  HGNC, UniProt                                SLC47A1, Q96FL8                                                                                   SLC47A2, Q86VL8
  Endogenous substrates                        creatine [@b439], thiamine [@b439]                                                                creatine [@b439], thiamine [@b439]
  Substrates                                   cimetidine [@b437], quinidine [@b439], paraquat [@b434], cephradine [@b439], cephalexin [@b439]   cimetidine [@b436], MPP+ [@b436], N1-methylnicotinamide [@b436], metformin [@b436], guanidine [@b439], procainamide [@b436], acyclovir [@b439]
  (Sub)family-selective inhibitors (pIC~50~)   pyrimethamine (p*K*~i~ 6.8), cimetidine (p*K*~i~ 6.0) [@b441]                                     pyrimethamine (p*K*~i~ 6.3 - Mouse) [@b435], cimetidine (p*K*~i~ 5.1) [@b441]
  Radioligands (*K*~d~)                        \[14C\]metformin [@b439],[@b440], \[14C\]TEA [@b438],[@b440]                                      \[14C\]TEA [@b439]
  -------------------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------

Comments
========

DAPI has been used to allow quantification of MATE1 and MATE2-mediated transport activity [@b442]. MATE2 and MATE2-B are inactive splice variants of MATE2-K [@b436].

SLC48 heme transporter
======================

Overview
--------

HRG1 has been identified as a cell surface and lysosomal heme transporter [@b445]. In addition, evidence suggests this 4TM-containing protein associates with the V-ATPase in lysosomes [@b444]. Recent studies confirm its lysosomal location and demonstrate that it has an important physiological function in macrophages ingesting senescent red blood cells (erythrophagocytosis), recycling heme (released from the red cell hemoglobin) from the phagolysosome into the cytosol, where the heme is subsequently catabolized to recycle the iron [@b446].

  ------------------------- ------------------
  Nomenclature              Heme transporter
  Systematic nomenclature   SLC48A1
  Common abbreviation       HRG1
  HGNC, UniProt             SLC48A1, Q6P1K1
  ------------------------- ------------------

SLC49 family of FLVCR-related heme transporters
===============================================

Overview
--------

FLVCR1 was initially identified as a cell-surface attachment site for feline leukemia virus subgroup C [@b455], and later identified as a cell surface accumulation which exports heme from the cytosol [@b452]. A recent study indicates that an isoform of FLVCR1 is located in the mitochondria, the site of the final steps of heme synthesis, and appears to transport heme into the cytosol [@b448]. FLVCR-mediated heme transport is essential for erythropoiesis. Flvcr1 gene mutations have been identified as the cause of PCARP (posterior column ataxia with retinitis pigmentosa (PCARP) [@b453].There are three paralogs of FLVCR1 in the human genome.

FLVCR2, most similar to FLVCR1 [@b450], has been reported to function as a heme importer [@b449]. In addition, a congenital syndrome of proliferative vasculopathy and hydranencephaly, also known as Fowler\'s syndrome, is associated with a loss-of-function mutation in FLVCR2 [@b451].

The functions of the other two members of the SLC49 family, MFSD7 and DIRC2, are unknown, although DIRC2 has been implicated in hereditary renal carcinomas [@b447].

  ------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------- --------------------------------
  Nomenclature              Feline leukemia virus subgroup C cellular receptor family, member 1   Feline leukemia virus subgroup C cellular receptor family, member 2   Major facilitator superfamily domain containing 7   Disrupted in renal carcinoma 2
  Systematic nomenclature   SLC49A1                                                               SLC49A2                                                               SLC49A3                                             SLC49A4
  Common abbreviation       FLVCR1                                                                FLVCR2                                                                MFSD7                                               DIRC2
  HGNC, UniProt             FLVCR1, Q9Y5Y0                                                        FLVCR2, Q9UPI3                                                        MFSD7, Q6UXD7                                       DIRC2, Q96SL1
  Substrates                heme [@b452]                                                          heme [@b449]                                                          --                                                  --
  Stoichiometry             Unknown                                                               Unknown                                                               Unknown                                             Unknown
  ------------------------- --------------------------------------------------------------------- --------------------------------------------------------------------- --------------------------------------------------- --------------------------------

Comments
========

Non-functional splice alternatives of FLVCR1 have been implicated as a cause of a congenital red cell aplasia, Diamond Blackfan anemia [@b454].

SLC50 sugar transporter
=======================

Overview
--------

A mouse stromal cell cDNA library was used to clone C2.3 [@b457], later termed Rag1-activating protein 1, with a sequence homology predictive of a 4TM topology. The plant orthologues, termed SWEETs, appear to be 7 TM proteins, with extracellular N-termini, and the capacity for bidirectional flux of D-glucose [@b456]. Expression of mouse SWEET in the mammary gland was suggestive of a role in Golgi lactose synthesis [@b456].

  ------------------------- ----------------------
  Nomenclature              SLC50 sugar exporter
  Systematic nomenclature   SLC50A1
  Common abbreviation       RAG1AP1
  HGNC, UniProt             SLC50A1, Q9BRV3
  ------------------------- ----------------------

SLC51 family of steroid-derived molecule transporters
=====================================================

Overview
--------

The SLC51 organic solute transporter family of transporters is a pair of heterodimeric proteins which regulate bile salt movements in the bile duct, small intestine and kidney, and elsewhere, as part of the enterohepatic circulation [@b458],[@b460]. OSTα/OSTβ is also expressed in steroidogenic cells of the brain and adrenal gland, where it may contribute to steroid movement [@b461]. Bile acid transport is suggested to be facilitative and independent of sodium, potassium, chloride ions or protons [@b458],[@b460]. OSTα/OSTβ heterodimers have been shown to transport \[3H\]taurocholic acid, \[3H\]DHEAS, \[3H\]estrone-3-sulphate, \[3H\]-pregnenolone sulphate and \[3H\]DHEAS [@b458],[@b460],[@b461]. OSTα is suggested to be a seven TM protein, while OSTβ is a single TM 'ancillary' protein, both of which are thought to have intracellular C-termini [@b462]. Bimolecular fluorescence complementation studies suggest the possibility of OSTα homo-oligomers, as well as OSTα/OSTβ hetero-oligomers [@b459],[@b462].

  ------------------------- ---------------- ----------------
  Nomenclature              OSTα             OSTβ
  Systematic nomenclature   SLC51A1          SLC51A1BP
  HGNC, UniProt             SLC51A, Q86UW1   SLC51B, Q86UW2
  ------------------------- ---------------- ----------------

SLC52 family of riboflavin transporters
=======================================

Overview
--------

riboflavin, also known as vitamin B2, is a precursor of the enzyme cofactors flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD). Riboflavin transporters are predicted to possess 10 or 11 TM segments.

  ------------------------- ------------------------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------
  Nomenclature              solute carrier family 52 (riboflavin transporter), member 1   solute carrier family 52 (riboflavin transporter), member 2   solute carrier family 52 (riboflavin transporter), member 3
  Systematic nomenclature   SLC52A1                                                       SLC52A2                                                       SLC52A3
  Common abbreviation       RFVT1                                                         RFVT2                                                         RFVT3
  HGNC, UniProt             SLC52A1, Q9NWF4                                               SLC52A2, Q9HAB3                                               SLC52A3, Q9NQ40
  Endogenous substrates     riboflavin (Km 1.38x10^-9^ M) [@b463]                         riboflavin (Km 9.8x10^-10^ M) [@b463]                         riboflavin (Km 3.3x10^-10^ M) [@b463]
  Stoichiometry             Unknown                                                       Unknown                                                       H^+^-dependent
  ------------------------- ------------------------------------------------------------- ------------------------------------------------------------- -------------------------------------------------------------

Comments
========

Although expressed elsewhere, RFVT3 is found on the luminal surface of intestinal epithelium and is thought to mediate uptake of dietary riboflavin, while RFVT1 and RFVT2 are thought to allow movement from the epithelium into the blood.

SLCO family of organic anion transporting polypeptides
======================================================

Overview
--------

The SLCO superfamily is comprised of the organic anion transporting polypeptides (OATPs). The 11 human OATPs are divided into 6 families and ten subfamilies based on amino acid identity. These proteins are located on the plasma membrane of cells throughout the body. They have 12 TM domains and intracellular termini, with multiple putative glycosylation sites. OATPs mediate the sodium-independent uptake of a wide range of amphiphilic substrates, including many drugs and toxins. Due to the multispecificity of these proteins, this guide lists classes of substrates and inhibitors for each family member. More comprehensive lists of substrates, inhibitors, and their relative affinities may be found in the review articles listed below.

  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------
  Nomenclature              OATP1A2                                                                                                                                                                    OATP1B1                                                                                                                                                                                                                         OATP1B3                                                                                                                                                                                                      OATP1C1
  Systematic nomenclature   SLCO1A2                                                                                                                                                                    SLCO1B1                                                                                                                                                                                                                         SLCO1B3                                                                                                                                                                                                      SLCO1C1
  HGNC, UniProt             SLCO1A2, P46721                                                                                                                                                            SLCO1B1, Q9Y6L6                                                                                                                                                                                                                 SLCO1B3, Q9NPD5                                                                                                                                                                                              SLCO1C1, Q9NYB5
  Endogenous substrates     PGE2, bilirubin, bile acids, steroid conjugates, thyroid hormones                                                                                                          bilirubin, bile acids, leukotrienes, steroid conjugates, thyroid hormones                                                                                                                                                       CCK-8, LTC4, bilirubin, bile acids, steroid conjugates, thyroid hormones                                                                                                                                     steroid conjugates, thyroid hormones
  Substrates                deltorphin II, rosuvastatin, BSP, talinolol, microcystin, fexofenadine, ouabain, antibiotics, anticancer drugs, beta blockers, fluoroquinolones, HIV protease inhibitors   rifampicin, BSP, fexofenadine, ACE inhibitors, anticancer drugs, antifungals, β-lactam antibiotics, bile acid derivatives and conjugates, endothelin receptor antagonists, HIV protease inhibitors, opioids, sartans, statins   erythromycin-A, rifampicin, BSP, amanitin, digoxin, phalloidin, saquinavir, fexofenadine, ouabain, anticancer drugs, β-lactam antibiotics, bile acid derivatives and conjugates, opioids, sartans, statins   BSP, statins
  Inhibitors (pIC~50~)      naringin, rifampicin, rifamycin SV                                                                                                                                         cyclosporin A, gemfibrozil, glycyrrhizin, indocyanine Green, rifampicin, rifamycin SV, sildenafil                                                                                                                               cyclosporin A, gemfibrozil, glycyrrhizin, rifampicin, rifamycin SV, sildenafil                                                                                                                               DPDPE, probenecid, taurocholic acid
  Radioligands (*K*~d~)     \[3H\]BSP, \[3H\]DPDPE, \[3H\]estrone-3-sulphate                                                                                                                           \[3H\]estradiol-17β-glucuronide, \[3H\]estrone-3-sulphate                                                                                                                                                                       \[3H\]BSP, \[3H\]CCK-8 (human, mouse, rat), \[3H\]estradiol-17β-glucuronide                                                                                                                                  \[125I\]thyroxine, \[3H\]BSP, \[3H\]estrone-3-sulphate
  Comment                   --                                                                                                                                                                         Other inhibitors include fibrates, flavonoids, glitazones and macrolide antibiotics. pravastatin is used as a probe                                                                                                             Other inhibitors include HIV protease inhibitors, glitazones and macrolide antibiotics                                                                                                                       --
  ------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------

  ------------------------- ------------------------------------- ---------------------------------------------------------------------------------------------------- ------------------------------------------------------
  Nomenclature              OATP2A1                               OATP2B1                                                                                              OATP3A1
  Systematic nomenclature   SLCO2A1                               SLCO2B1                                                                                              SLCO3A1
  HGNC, UniProt             SLCO2A1, Q92959                       SLCO2B1, O94956                                                                                      SLCO3A1, Q9UIG8
  Endogenous substrates     eicosanoids, prostaglandins           T4, dehydroepiandrosterone sulphate, estrone-3-sulphate                                              BQ123, vasopressin, prostaglandins, thyroid hormones
  Substrates                synthetic prostaglandin derivatives   telmisartan, glibenclamide, amiodarone, bosentan, BSP, talinolol, aliskiren, fexofenadine, statins   --
  Inhibitors (pIC~50~)      bromocresol green, BSP                gemfibrozil, glibenclamide, rifamycin SV                                                             --
  Radioligands (*K*~d~)     \[3H\]PGE2                            \[3H\]BSP, \[3H\]estrone-3-sulphate                                                                  \[3H\]estrone-3-sulphate, \[3H\]PGE2
  Comment                   Other inhibitors include NSAIDs       Other inhibitors include glitazones and citrus juices                                                --
  ------------------------- ------------------------------------- ---------------------------------------------------------------------------------------------------- ------------------------------------------------------

  ------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------------- ----------------- -----------------
  Nomenclature              OATP4A1                                                            OATP4C1                                                                   OATP5A1           OATP6A1
  Systematic nomenclature   SLCO4A1                                                            SLCO4C1                                                                   SLCO5A1           SLCO6A1
  HGNC, UniProt             SLCO4A1, Q96BD0                                                    SLCO4C1, Q6ZQN7                                                           SLCO5A1, Q9H2Y9   SLCO6A1, Q86UG4
  Endogenous substrates     bile acids, prostaglandins, steroid conjugates, thyroid hormones   cAMP, steroid conjugates, thyroid hormones                                --                --
  Substrates                penicillin G                                                       anticancer drugs, cardiac glycosides, dipeptidyl peptidase-4 inhibitors   --                --
  Radioligands (*K*~d~)     \[3H\]estrone-3-sulphate                                           \[3H\]digoxin                                                             --                --
  ------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------------- ----------------- -----------------
